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A B S T RAe T
i
Incubations of several polycyclic heteroaromatic compounds and two
polycyclic aromatic hydrocarbons with a series of common fungi have been
The ATCC 26269,
arrhizus ATCC 11145, and Mortierella isabellina NRRL 1757 were
studied in this regard. Of the aza heteroaromatics, only dibenzopyrrole
gave a ring hydroxylated product following the incubation with C.
ii
e1egans. From the thio heteroaromatics studied, dibenzothiophene was
metabolized by all the three fungi and thioxanthone by C. and
M. isabe11ina giving sulfones and sulphoxides. Thiochromanone was
metabolized stereose1ective1y to the corresponding sulphoxide by C.
e1egans. Methyl substituted thioxanthones on incubation with C.
e1egans produced oxidative products, arising from S -oxidation and
hydroxylation at the methyl group. Of the cyclic ketones studied, only
fluorenone was reduced to hydroxyf1uorene and this metabolism is
compared with that reported with cytochrome P-450 monooxygenases of
hepatic microsomes.
A series of para-substituted ethy1benzenes has been transformed
stereoselective1y to the 1-phenylethano1s by incubation with ~
isabe11ina. of the enantiomeric ties obtained from
with their respective para substituent of the same steric size
but different electronic properties indicate that the stereoselectivi
of hydroxylation at benzylic carbon may be susceptible to electron
donating or withdrawing factors in some cases, but that observation is
not valid in all the comparisons. The stereochemistry of the reaction
is discussed in terms of three possible steps, ethylbenzene ---)
1-phenylethanol ---) acetophenone ---) 1-phenylethanol. This
metabolic pathway could account for the inconsistencies observed in the
comparisons of optical purities and electronic character of para
substituents. Furthermore, formation of 2-phenylethanol (in some
cases), 1-(p-acetylphenyl)ethanol from p-diethylbenzene, and
N-acetylation of p-ethylaniline was observed. n-Propylbenzene was also
converted to optically active 1-phenylpropanol.
Acetophenone, p-ethylacetophenone, and o<,~,~-trifluoroacetophenone
were transformed to 1-phenylethanol, 1-(p-ethylphenyl)ethanol, and
1-phenyl-2,2,2-trifluoroethanol, respectively, with high chemical and
excellent optical yields.
13The C NMR spectra of several substrates and metabolic
products have been reported and assigned for the first time.
iii
A C K NOW LED GEM E N T S
iv
I would like to thank Dr. H.L. Holland for his expert guidance,
boundless patience, encouragement, enthusiasm and thoughtful suggestions
the course of my studies, all of which has made this an
exceptionally pleasurable learning experience.
My grateful thanks are also extended to Mr. I.D. Brindle of Brock
University, Prof. D.B. MacLean of McMaster University, Prof. V. Snieckus
of University of Waterloo, Prof. I.W.J. Still of University of Toronto,
and Prof. P. Morand of University of Ottawa for providing some of the
compounds used in this study.
Special thanks are extended to Mr. Tim Jones for his expertise in
recording NMR and mass spectra. I am also thankful to Mr. Brian Sayer
and Mr. Ian Thompson of McMaster and Dr. R.E. Lenkinski of the
University of Guelph for 13C NMR spectra.
v
Sincere grati is accorded to Dr. Taj Mohammad, Dr. P.Ch.
Chenchiah, and Dr. J.K. Puri for many useful discussions.
I want to express my deep appreciation to Ron Ninnis and Benny
Munoz' for discussions. I am also grateful to Pam Warner for her
the course of this work.
Thanks go to my friends Jahangir, Saeed, Afzal,
and Naveed for their and moral support. I would like to thank my
fellow graduate students Julius, Naresh, Donna, and Elly for providing
the laughs when needed most.
I am also to Miss. Janet Hastie for her in typing
this manuscript.
Last but certainly not least, I am very grateful to my parents for
their never-ending support, unwavering kindness, love, patience, and
encouragement throughout the years.
vi
To
My Parents
Who made it all possible
vii
Introduction:
Part One:
Part Two:
Part Three:
Four:
Experimental:
Part One:
Part Two:
A.
1.
2.
3.
B.
C•.
Part Three:
Part Four:
Results:
Part One:
Part Two:
Part Three:
TABLE OF CONTENTS
Biotransformation of Polycyclic
Aromatic Compounds
Microbial Oxidation of Alkylbenzenes
Microbial Reduction of Ketones
Cytochrome P-450 : A Unified View
Apparatus, Materials and Methods
Synthesis of Substrates
Microbial Incubations
Biotransformation of Polycyclic
Aromatic Compounds
Incubations with C. elegans ATTC 26269
Incubations with ~ arrhizus ATCC 11145
Incubations with ~ isabellina NRRL 1757
Microbial Oxidation-of Alkylbenzenes
by M. isabellina NRRL 1757
Microbial Reduction of Ketones
by M. isabellina NRRL 1757
Determination of Enantiomeric Excess
Determination of Specific Rotations
Biotransformation of Polycyclic Aromatic
Compounds by Fungi
Microbial Oxidation of Alkylbenzenes
by M. isabellina NRRL 1757
Microbial Reduction of Ketones
by M. isabellina NRRL 1757
Page
3
31
51
56
85
88
120
147
150
153
164
167
171
175
180
184
viii
Discussion:
Part One:
Part Two:
References:
Appendix I:
References:
Appendix II:
Biotransformation of Polycyclic Aromatic
Compounds by Fungi
Microbial Oxidation of Alkylbenzenes
by M. isabellina NRRL 1757
Page
187
201
215
230
233
235
ix
Table
1.
2.
LIST OF TABLES
Page
13C NMR spectra of substrates, 7 and 8 94
13C NMR spectra of substrates, 1 , 2 , 3 , 4 , and 5 128
x
3.
4.
5.
6.
7.
Assignment of 13C NMR spectra of
Dibenzothiophene-9,9-dioxide, 37 ,
2-Hydroxydibenzopyrrole, 39 , and
9-Hydroxyfluorene, 40
13C NMR spectra of substrates, 16 , 18 ,and 20
Assignment of 13C NMR spectra of
Thiochromone-l-oxide, 42 and
Thioxanthone-l0,10-dioxide, 43
Assignment of 13C NMR spectra of
Methyl Substituted Thioxanthones, 21 , 22 , 23 ,and 24
Assignment of 13C NMR spectra of
Methyl Substituted Thioxanthone-l0,10-dioxides,
45 , 46 , !!2. ,and 48
129
138
139
145
146
8. Optical purities of products
9. Specific rotations of products and
their absolute configurations
10. Summary of Results (Part One)
11. Summary of Results (Part Two)
12. Summary of Results (Part Three)
169
172
175
180
184
LIST OF FIGURES
Figure Page
xi
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
Environmental PAHs
The NIH shift during monooxygenase-catalysed
formation of phenols
Metabolism of Benzene Oxide
Possible sites for bioactivation in a PAH
K-region oxides that have been identified
as metabolites of PAHs
Mutagens isolated from the basic fraction of coal tar
Carcinogenic PACs
Possible bioactivated metabolites of benz[a]acridine
Metabolic pathways utilized by eucaryotic and
procaryotic organisms for the oxidation
of aromatic hydrocarbons
Reactions utilized by mammals for the metabolism of PAHs
Pathways for Toluene metabolism
Proposed mechanisms for Ethylbenzene hydroxylation
in rats
Proposed mechanisms for Ethylbenzene hydroxylation
in rats
4
8
10
11
13
17
19
20
23
24
34
36
37
14. Metabolic routes of Deuterium labelled
41
15. Reaction sequences utilized by P.
to oxidize Ethylbenzene 42
16.
17.
Hydroxylation of substituted 1,3-Diphenylpropanes
Microsomal hydroxylation reaction
of 1,3-Diphenyl-[1,1-d2]propane
44
46
Figure
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
Reactions catalysed by p-Cresol methylhydrolase
Microbial reduction of ketones
Protoheme group of Cytochrome P-450
The catalytic cycle of Cytochrome P-450 dependent
monooxygenases
Spin transition in Cytochrome P-450
Reduction of Cytochrome P-450
Possible routes for hydroxylation at saturated carbon
Hydroxylation of Cyclopropane and Methylcyclopropane by
M. capsulatus
Rearrangement during Dieldrin metabolism
Hydroxylation of Norbornane by Liver Cytochrome P-450
Hydroxylation of Camphor of by Cytochrome P-450
cam
Possible routes for epoxidation at olefinic carbon by
Cytochrome P-450
Proposed mechanism for sulphoxidation by Cytochrome P-450
Synthesis of Dihydronorharman, ~
Proposed route for the synthesis of
1,1,1-Trifluoroethylbenzene
The structure of chiral shift reagent
Proposed reaction for the metabolism of Dibenzopyrrole by
c. elegans
Mechanism of enzymic sulphide oxidation
Page
48
53
60
62
63
65
68
71
73
74
76
79
81
95
117
168
188
193
xii
Figure
36. Microbial metabolism of 4-methylbenz[a]anthracene by the
fungus C.
Page
195
xiii
37. Transformation of 1- and 2-methylnaphthlenes by C. 196
38. Model for the binding of a para-substituted 204
39.
40.
41.
Proposed metabolic pathway for the hydroxylation of
alkylbenzenes
Hydroxylation of 0(,0( -d2 ethylbenzene and1-(4-phenylethyl)-ethane-1,1-d2
Sulphide oxidation by Mortierella isabellina
208
212
212
I N T ROD U C T ION
1
PART ONE
Biotransformation of Polycyclic Aromatic Compounds
2
Polycyclic aromatic hydrocarbons (PAHs) are found in air, soils and
sediments around the world. 1 They are in great variety (Fig. 1), of
unusual chemical stability, and their origins are widespread.
Polycyclic aromatic molecular structures are formed whenever
organic substances are exposed to high temperatures, through a process
called pyrolysis. Given enough time, aromatization proceeds at even
lower temperatures. The aromatic hydrocarbons of crude oil are formed
over millions of years in sediments that are at temperatures between
100° and 150°C.
A quite different pattern is observed when the temperature of
formation is lower. That pattern is best illustrated by the analysis of
crude oils; there alkylated polycyclic aromatic hydrocarbons far exceed
the unsubstituted ones, and the average degree of alkylation and the
maximum number of carbons on the aromatic rings are far higher than they
are in samples produced by high temperature pyrolysis.
It has been conjectured that polycyclic aromatic hydrocarbons are
being produced today by thermal processes in soils at environmental
temperatures. The isolation of benz ]pyrene in rural soils stimulated
world wide analysis. By the end of the 1960's, it was generally
accepted that from 10 to 15 hydrocarbons which show an intense
fluorescence in ultraviolet radiation are present in most if not all
soils in similar proportions everywhere. Unsubstituted aromatic
hydrocarbons are the most abundant; are accompanied by extended
3
4Figure 1. Environmental PARs
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series of substituted members containing alkyl group and saturated
five-member rings.
The ring arrangements in polycyclic aromatic hydrocarbons can be
divided into three broad categories (Fig. 1): linear (with all the
rings in a line), angular (with the rings in steps) and clustered (with
at least one ring surrounded on three sides). The various arrangements
differ in their stability. The linear arrangement in anthracene and
tetracene is the least stable. Clusters of benzene rings, as in pyrene,
benzopyrene and pery1ene, are more stable and are commonly found in
pyro1ysates. The most stable configuration is the angular arrangement
of benzene rings in phenanthrene, chrysene and picene. The last
category of compounds is common in soils, sediments, wood tar, tobacco
smoke, petroleum and atuomobi1e-exhaust gases.
PAHs from pyrolysis have been present on the earth for a long time.
Human population has been chronically exposed to combustion products
~h~~n~hn,nt its history, and natural fires and reactions in sediments
formed polycyclic aromatic hydrocarbons long before the advent of man.
Moreover, hydrocarbons in smoke, in fallout from polluted air, in
sediments and fossil fuels also come in contact with man.
PAHs now enter the environment in amounts than they did in
the early stages of evolution, and from some recognized
2 3
sources.' The major sources include the incomplete combustion of
wood, coals, the spillage of raw or refined petroleum and metal smelting
5
Polycyclic aromatic hydrocarbons are noted for their biological
effects. Some of them can induce cancer or cause mutations, even in
very low concentrations. This discovery caused a great concern among
scientists. Environmental chemists, geochemists and toxicologists
pursued the study of identification of polycyclic aromatic hydrocarbons
and their natural pathways of metabolism to assess the effects of
release of these compounds into the environment. The environmental
mixture of aromatic hydrocarbons is exceedingly complex, displays a wide
range of cancer inducing activity4, has many sources, and is
difficult to analyze. Since many of these compounds have never been
tested for their biological activity, it seems important to do a
thorough investigation of the environmental effects of the new influx of
these substances. The present study (in part) is a step towards the
examination of these compounds in biological systems in the light of our
present knowledge of the subject.
The metabolic conversion of aromatic compounds to phenols in
mammals has long been considered a means for the detoxification and
excretion of a variety of foreign compounds and environmental
pollutants. The idea began to emerge that the biotransformation of
foreign compounds into less lipid-soluble products, which would be more
readily excretable from the body, might well confer a protective
function.
The major pathways for metabolism of polycyclic aromatic compounds
in biological systems are catalysed primarily by a class of nonspecific
6
monooxygenases known as cytochrome P-450. Cytochrome P-450 activity is
localized in the endoplasmic reticulum (microsomal fraction) of cells
7
from liver, lung, , intestine, and skin. Highest activities of
P-450 are found in liver.
Recent investigations5- 7 into the mechanism by which hepatic
monooxygenase enzymes catalyse the formation of phenols have, however,
revealed that highly carcinogenic arene oxides, compounds in which a
formal aromatic double bond has undergone epoxidation, are intermediates
in the reaction. Identification of arene oxides as intermediates in the
metabolic formation of phenols and the realization that the carcinogenic
activity of polycyclic aromatic compounds is only manifested following
their metabolism 5-7 has stimulated a great surge of interest among
the researchers to exploit this new aspect of metabolism and fate of
PAHs in mammalian,8 bacterial,9 and fungal10- 13 systems.
The migration and retention of substituents that occur during the
monooxygenase-catalysed formation of phenols from most aromatic
substances has been termed as the "NIH shift".14. The occurrence of
this shift suggested that the "aromatic hydroxylations" are actually
epoxidations and that the intermediate arene oxides undergo a ready
isomerization to phenols with concomitant and retention of
substituents (Fig. 2). A wide variety of substituents including
isotopes of hydrogen, halogens and allyl groups have been observed to
migrate in this way, and monooxygenases from plants, microorganisms, and
· 1 1 h··· 1 °d· 15,16an1ma s cata yse t e 1n1t1a epOX1 at10ns.
Figure 2. The NIH shift during the monooxygenase-catalysed formation
of phenols
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Arene oxides, in addition to isomerization to phenols, react
9
readi with nucleophiles such as glutathione, and undergo enzymatic
hydration (Fig. 3). The steady-state concentrations of arene oxides
depend on the rates at which they are formed and their ability to
undergo the above mentioned transformations.
Aromatic compounds with an oxidizable substituent, such as the
methyl group in toluene, are often metabolized to a large extent at such
moieties rather than by way of arene oxide formation of the ring. The
relative extent of formation of different oxides and other metabolites
from an aromatic substrate will, of course, depend on the biological
system.
The stability of a particular arene oxide will also influence the
extent of its nonenzymatic reactions with a variety of nucleophiles,
including such intracellular macromolecules as DNA, RNA and protein.
Virtually nothing is known of the relative stability of these isomeric
oxides except that the K-region oxides are considerably more stable than
h K e ed 5t e non- -reg1on OX1 es. A UK-regionU is defined as the external
corner of a phenanthrenenic moiety in a PAH (Fig. 4). The UK-regionU
e 1 d e f h P 11 h 17 de h- hterm1no ogy er1ves rom t e u man t eory ,accor 1ng to w 1C
polyarenes were considered to be distinguished an
electron rich bond, such as 4,5 bond of B.P., which is termed as the
UK-region" and excision of which leaves a fully aromatic polyarene ring
system. Direct evidence has now been provided that K-region oxides are
formed as metabolic intermediates from 18
Figure 3. Metabolism of Benzene Oxide
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Figure 4. Possible sites for bioactivation in a PAR
11
benzo[a]anthracene,18 dibenzo[a,h]]anthracene,18,19
20 20 21pyrene, and benzo[a]pyrene ' in the 4,5 position (Fig. 5).
D 81 d 8 8 8 22,23 f h h 8 f 8 8 8eta1 e 1nvest1gat10ns 0 t e mec an1sm 0 1somer1zat10n
have indicated that carbonium ions (Fig. 2) are formed during the rate
determining steps in these reactions. The formation of phenol depends
upon the relative stabilization of such transient carbonium ion
intermediates. In certain instances, these carbonium ions are readily
trapped by reaction with solvent molecules. 24 ,25 This facile
solvolysis is indicative of how readily arene oxides should be able to
bind even to very weak nucleophilic sites within the cell. On the other
hand, the results from the addition of glutathione indicate that
nucleophilic opening of the oxide can take place, rather than trapping
of an intermediate carbonium ion.
The complexity of the reactions of arene oxides with simple
nucleophiles indicate that reactions with DNA, RNA and protein will in
all likelihood proceed by many pathways.
A variety of chemicals have been implicated as causative agents in
carcinogenesis. Each of the chemical caracinogens that has been
thoroughly studied has been found to bind covalently with DNA, RNA and
8 f h 8 26prote1n 0 t e target t1ssue.
12
However, PAHs do not covalently bind to biopo without prior
specific bioactivation; presumably a monooxygenase, cytochrome P-450
catalysed conversion to arene oxide. The magnitude of the weak physical
Figure 5. K-region oxides that have been identified as metabolites
of PARs
13
binding which occurs between the hydrocarbons and macromolecules does
27
not correlate with the carcinogenic efficacy of the hydrocarbon.
Thus, arene oxides have become prime candidates for the bioactivated
intermediates responsible for the covalent bonding of aromatic compounds
to biopolymers within the cell. 28- 31 Since the toxic, carcinogenic,
and mutagenic effects of PAHs often correlate with the extent of this
bonding, it provides a molecular basis for these effects and reveals
arene oxides as causative agents in producing these effects. Covalent
binding alone, however, cannot be considered a sufficient criterion for
carcinogenesis; benz[a,c]anthracene and the [a,h] isomer bind equally
11 k o 1 h 1 d··· 32we to mouse s 1n, yet on y te atter compoun 1S carc1nogen1C.
The proposal that arene oxides are the bioactivated intermediates
responsible for the binding and the carcinogenic effects of PAHs is
attractive. However, the possibility that metabolites other than arene
14
oxides also have a role in the carcinogenicity should
excluded.
not be
Some studies did not implicate arene oxides as the ultimate
carcinogens formed from PAHs. Carcinogenicity tests show the arene
oxides to general less active than the parent
33 34hydrocarbons.' While activated metabolites might be expected to
exhibit greater activi than their precursors, these negative results,
however, may be the consequence of transport and/or inactivation
phenomena, due to decomposition or secondary reaction of these oxides in
the intact organism prior to reaching the critical target macromolecule.
Although these studies have been highly informative, questions such
as whether or not K-region oxides, non-K-region oxides, or subsequent
metabolites are the ultimate carcinogens or mutagens remain to be
answered, perhaps through careful parallel comparisons of biochemical
formation and disposition of hydrocarabon metabolites and their
biological effects. One of the biochemical parameter of relevance is
the nature and extent of binding of metabolically active PAHs and of
their various derivatives to biopolymers.
The nature of the sites of binding to biopolymers and the complex
set of kinetic and structural parameters that influences both the
reactivity of arene oxides and their ability to bind to critical target
molecules is under investigation, but such factors have not been
completely defined.
Throughout the development of this field of knowledge, the
operation of biochemical reaction had been assumed, and the
establishment of enzyme-catalysed mechanisms for the reaction of foreign
compounds and for intermediate metabolites strongly supported this
supposition. Nevertheless, review of the literature35 indicated
some metabolites, which were unlikely to result from biotransformations
15
alone. e eb e 1 36 hreact10ns contr1 ute more extens1ve y to t e
metabolism of compounds in mammals than is generally supposed.
Thus, this aspect of chemical transformations in biological systems can
not be ignored completely during the investigation of the metabolic fate
of PAHs in these systems.
A large effort has been made to the study of PAHs and their role as
potent carcinogens in biological systems. On the other hand, such
studies of heteroanalogs of PAHs are quite poor. However, the presence
of aza, thia and oxa aromatics as environmental atmospheric pollutants
. 37-39has recently been recogn1zed. • Polycylic aromatic compounds
(PACs) as distinct from the hydrocarbons (PAHs) are formed from both
natural and anthropogenic sources; the latter are by far the major
contributors. Natural sources include forest fires, volcanoes and
synthesis from degraded biological substances. Recently, Kosuge
et al 39 reported the isolation of five nitrogen containing PACs
from basic fractions of coal tar and all of them appeared to be mutagens
(Fig. 6). Major anthropogenic sources include the burning of coal,
residential fireplaces, automobile exhausts, coal-fired residential
furnaces, oil-fired commercial boilers, commercial incinerators and
rubber tyre wear. A minor source in terms of total PAC production, but
of considerable importance with respect to human health, is tobacco
smoking. Until the beginning of this century there existed a natural
balance between the production and natural degradation of PACs, which
the background concentration low and fixed. However, with
16
industrial development throughout the world, the natural
balance has been disturbed and the production and accumulation rates of
PACs are cons increasing. These compounds have also been
identified as components of urban air particles. Because of their
distribution, they may represent an inhalation hazard in both the
occupational and general environment.
Figure 6. Mutagens isolated from the basic fraction of coal tar
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Phenaleno[1,9-gh]quinoline
Pyrido[3,Z-c]carbazole
Benzo[h]naptho[Z,l,S-def]-
quinoline
Quino[3,Z-c]carbazole
Benzo[de]naptho[1,8-gh]quinoline
In view of demonstrated carcinogenic or mutagenic behaviour of many
PACs (Fig. 6 and 7), efforts had been made to characterize these
compounds in various environmental sources, with which human population
may come in contact or to which they might be exposed. In contrast
studies on the metabolism of such compounds in biological systems are
18
l OOt d 39-431m1 e • However, the preliminary results suggested a
The bioactivated
relationship between the biochemical metabolic pathways of PAHs and
their heteroanalogs in the sense that the latter also require
Ubioactivation" catalysed by monooxygenase cytochrome P-450 to show
o d 0 0 ff t 40 ,44mutagen1c an carc1nogen1,c e ec s.
metabolites are presumably those forms which ultimately attack critical
cellular components, possibly nucleic acids. In particular, oxidation
reactions on angular benzo rings, leading ultimately to so-called "bay
region" dihydrodiol epoxide and carbonium ion forms (Fig. 8) appear to
be central to carcinogenic activation in PACs. The term "bay region"
refers to concave, exterior topological region of the hydrocarbon
bordered by three benzene rings, one of which must be a terminal ring.
The typical example of bay region is the sterically hindered area
between the 1 and 12 positions in benzacridines (Fig. 7). Experiments
with benzacridines42 indicated epoxidation and hydrolysis of the
epoxides to dihydrodiols to be the predominant metabolic pathways.
However, no unequivocal evidence could be obtained for the formation of
ultimate carcinogen, the 3,4 dihydrodiol-l,2-epoxides in case of the
19
Figure 7. Carcinogenic PACs
Quinoline Phenanthridine Benzo[h]quinoline Benzo[f]quinoline
Benz[a]acridine Benz[c]acridine
Dibenz[ c, h] a.cridine
Figure 8. possible bioactivated metabolites of benz[a]acridine
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OH
OH
OH
benz[a] and benz[c]acridine.
Further detailed studies regarding the structural requirements and
mutagenic and carcinogenic activity of putative metabolites of
1 1 - h - d· 45-48po ycyc 1C eteroaromat1c compoun s are 1n progress.
Very little is known about the properties of polycyclic
heteroaromatic compounds, although numerous aza-PAH are carcinogens and
are known to be environmental contaminants present in urban atmosphere,
tobacco smoke and automobile exhausts. Several different bacterial and
fungal species which may possess the capabilities to metabolize these
compounds have been isolated from terrestrial and aquatic environments.
It therefore is of interest to study the metabolite profiles of these
compounds; this aspect of investigation is of great environmental
21
importance in that it provides knowledge about the in vivo formation
of highly carcinogenic, mutagenic and toxic arene oxide metabolites in
the natural environment (soil, water, air etc.) of the microorganisms
concerned.
Recent research in this fast-developing field have shown trans
dihydrodiol epoxide to be the activated mutagenic form of certain
PAH 49 0 h·· / -. d· 50-55 hs. t er 1n V1VO ~ v1tro stu 1es ave
revealed the adduct formation of these putative metabolites their
precursors with DNA and/or RNA. In most cases, the adduct formation
through covalent bonding has been indicated.
One of the very interesting and important observations made in the
last few years by Cerniglia, Gibson and MorganS6 ,S7 is that some
eucaryotic microbes, e.g., use
mono-oxygenative enzymic mechanisms for the ring attack of polycyclic
aromatic compounds, as do the mammals, to initiate detoxification
22
reactions; arene oxides can undergo isomerization to yield Is and
can also serve as substrate for the enzyme epoxide hydratase which
catalyses the addition of water to yield trans-dihydrodiols. In
contrast, bacteria utilize a dioxygenase enzyme system that incorporates
both atoms of molecular oxygen into the substrate to form
cis-dihydrodiols (Fig. 9). 58In another study, bacterial oxidation
of PAHs to cis-dihydrodiols has been shown. It can be seen that the
determination of the relative stereochemistry of dihydrodiols formed by
different biological systems is important since such information
provides evidence for the reaction mechanisms utilized in the enzymic
oxygenation of aromatic hydrocarbons.
Mammalian enzymes involved in the metabolism of aromatic compounds
have been subjected to intensive investigations. It is now known that
the oxidation and subsequent elimination of aromatic hydrocarbons from
animals occur through reactions mediated by cytochrome P_450,59
epoxide hydrolase,60 glutathione S-transferase60 and
61 62UDP-glucuronosyltransferase ' (fig. 10).
In contrast, information about the presence or function of these
enzymes in eukaryotic micro-organisms is limited. However, cytochrome
P-450 has been detected in several fungi. 63- 65 In the preliminary
63 66 .
studies by Ferris and co-workers ' uS1ng la
bainieri , it was observed that the hydroxylation of 4-[2H]-anisole
23
Figure 9. Metabolic pathways utilized by eucaryotic and procaryotic
organisms for the oxidation of aromatic hydrocarbons. The
dioxetane intermediate shown has not been formally
demonstrated.
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Figure 10. Reactions utilized by mammals for the metabolism of PAHs
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and 2-r 2H]-anisole proceded with migration and retention of isotopic
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hydrogen (NIH The formation of the trans-dihydrodiol of the
naphthalene and the incorporation of only one atom of oxygen-i8 from
1802 into the trans-dihydrodiol are consistent with naphthalene
oxide as an intermediate and the presence of an epoxide hydrase in C.
bainieri. The product ratios in these hydroxylations were very similar
to those obtained using liver microsomes. c. bainieri also
that the metabolism
metabolises aniline by aryl hydroxylation, aminopyrine by
O-demethylation, and nitro- and azo- compounds by reduction under
anaerobic conditions; these transformations are all typical of reactions
catalysed by liver microsomes. This evidence suggests that there is a
close similarity between fungal and mammalian cyclochrome P-450. The
enzymic activity in the fungi is inhibited by CO, SKF 525-A and
metyrapone, but not cyanide. These data together with the pattern of
stimulation by metal ions, suggest that fungal enzymatic activity is due
to a cytochrome P-450, similar to the one present in mammalian liver.
The conclusion was confirmed when a maximum absorbance at 450 nm was
observed in the difference spectrum of the fungal hydroxylase after
reduction with dithionite and addition of CO.
In another s ,Gibson et al 64
of by crude microsomal preparations from C. is
very similar to that observed with hepatic microsomes and reconstituted
enzyme systems that contain partially purified preparations of
cytochrome P-450. This conclusion was based on the observations that
specific cytochrome P-450 inhibitors, carbon monoxide, SKF-525~A and
metyrapone, reduced the formation of trans -naphthalene dihydrodiol and
1-napthol by the microsomal preparations. The insensitivity of the
system to cyanide is also a property of cytochrome P-450. These results
26
are similar to those reported for enzymic
organism C. bainieri.
in the related
The level of cytochrome P-450 in the microsomal preparations of C.
was much lower than that in hepatic microsomes, but was quite
similar to the level found in C. bainieri.
Recent studies64 ,67 have demonstrated that C. elegans
contains epoxide hydrolase, glutathione S-transferase and
UDP-glucuronosyltransferase activities which share several properties
with the same enzymes found in mammalian liver.
In summary, C. elegans contains enzyme activities involved in the
transformation of polycyclic aromatic compounds that are similar to
those found in mammals. Further investigations will be required to
determine whether these enzymes participate in essential metabolic
reactions or are present to protect the fungus from the effects of
environmental chemicals.
10A screening programme revealed that forty seven species of
fungi belonging to thirty-four genera from the major fungal taxa have
the ability to metabo1ise naphthalene. The predominant metabolite
formed by most organisms was i-naphthol. Trans
-1,2-dihydroxy-l,2-dihydronaphthalene was also identified among other
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products. The fungi surveyed include organisms that are found in
terrestrial, freshwater and marine ecosystems.
Thorough survey of the literature has shown remarkable similarities
between the metabolism of aromatic compounds by mammals and many fungal
species. For example, NIH shift and incorporation of one atom of
oxidizeselegansc.stimulation shown by C.
molecular oxygen during metabolism of various substrates with a range of
f tI 66,68,69 broad t ttl tit d the e hebe e 1ungl., spec rum ac l.V1 y an l.n·l.··l.t10n p us
b ee . 63,66al.n1erl. ,
56 70 e 71 11
naphthalene, anthracene, bl.phenyl, benzo[a]pyrene, and
3-methylcholanthrene to complex mixtures of hydroxylated products that
are remarkably similar to those produced by mammalian liver. A
63 64
cytochrome P-450 monooxygenase ' has already been detected and
64 67 .
recently the presence of enzyme epoxide hydrolase, ' glutath10ne
67 67S-transferase, and UDP-glucuronosyltransferase activity similar to
hepatic microsomes has been established in many fungi. The results
suggest definite similarities between the enzyme systems used by fungi
and cytochrome P-450 dependent mono-oxygenase activity that is
associated with mammalian liver microsomes.
Now the question arises whether the fungi can be used as a model of
mammalian metabolism. The knowledge we obtained in this field so far
clearly indicates that it might be possible to define a microbial
transformation system which would mimic many types of biotransformations
reported to occur in mammals. Such a microbial transformation system,
consisting of a selected series of microorganisms, could advantageously
be used to conduct parallel mammalian and microbial studies of foreign
compound metabolism. When metabolites common to both systems are
observed, the microbial system would be utilized in obtaining sizable
quantities of metabolites via routine incubation techniques. By this
process, difficult to synthesize metabolites could be easily obtained
for structure elucidation and biological testing. The preparative scale
capacity of fungal incubations as well as experimental reproducibility
guaranteed by the availability of standardized cultures offer immediate
advantages over mammalian systems.
To test the ease of using microbial systems to mimic mammalian
metabolic patterns, attention has been focussed on a single type of
reaction, aromatic hydroxylation. This particular reaction was selected
for several reasons: first, it is the most common mammalian
biotransformation; second, aryl hydroxylase activity similar to that
displaced by mammalian cytochrome P-450 has been demonstrated in several
microbial species; third, phenol formation takes place via arene oxide
intermediate which is recognized as an immediate carcinogenic metabolite
of PAHs.
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Rosazza and
of great importance
72-75 have exploited this interesting aspect
a series of experiments. They chose
micro-organisms from among a wide variety of generae of fungi and did
the incubations with various model compounds varying in functionalities.
In most instances, the microbial model system gave good
correlations with reported metabolic les of hepatic microsomes
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and/or in vivo mammalian systems.
Although some metabolites were estimated to occur in low overall
yields, it should be emphasized that it is usual possible to improve
yields significantly by adjusting a number of incubation parameters to
obtain optimum conditions.
Minor mammalian metabolites were often found as major metabolites of
several fungi. However, with most compounds, one or more fungi
consistently demonstrated the ability to produce major mammalian
metabolites, thus confirming the idea that fungi may also serve as
useful models for the study of foreign compound metabolism in mammals.
Clearly, further studies are required to prove the versatility of
the present hypothesis. Nevertheless, the information revealed by these
experiments is of great value in understanding the metabolic pathways in
mammals and ultimately in man.
The present study (in part) explores the fate of polycyclic aromatic
compounds by fungal metabolism. Interest in the metabolism of PAHs and
their heteroanalogs by fungi stems from the fact that in addition to
their importance as widespread environmental organisms, many are
to possess metabolic capabilities which often closely relate
those of mammalian microsomes, and so fungal systems are being
used as a model for mammalian metabolism.
PART TWO
Microbial Oxidation of Alkylbenzenes
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In addition to the metabolism of various PAHs and their
heteroanalogs, the ability of cytochrome P-450 containing systems from
microbial and mammalian sources to oxidise the simple hydrocarbons was
recognized a long time ago, and since then these compounds have been the
subject of research. The substrates for this type of oxidation range
from the long chain aliphatic hydrocarbons to substituted alky1benzenes.
The distribution of isomeric alcohols, formed from alkanes by the
action of mammalian liver monooxygenase, has been measured. 76 All
of the possible isomeric alcohols were formed from methy1cyc1ohexane,
2-methylbutane, 2,2-dimethylpropane, isobutane, n-pentane and n-butane,
except for the primary alcohols of the latter three substrates. Common
features were the high degree of hydroxylation at secondary, relative to
primary, C-H bonds, and the preferred hydroxylation of tertiary C-H
bonds. The small size and lack of functional groups in these molecules
probably leads to no rigid orientation at the site of hydroxylation, and
product ratios could be governed by the reactivities of the various C-H
bonds. The specific activity of the enzyme was similar toward all
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substrates, and was induced four to fivefold on of rats
with the binding of the substrate to cytochrome P-450
also increased with the induction of enzyme activity.
n-Hexane is also hydroxylated by liver microsomes in all positions.
The preference is for 2-hydroxylation, but this is due to steric
factors, since the 2- and 3-positions are almost equivalent in chemical
reactivity_ Phenobarbital pretreatment induces 2- and 3-hydroxylation
sixfold; 3,4-benzpyrene suppresses 2- and stimulates 3-hydroxylation.
The inhibitors, metyrapone and 7,B-benzoflavone, have a differential
action on 3-hydroxylation. 77 Rat liver microsomal mono-oxygenase
also catalyse the hydroxylation of n-heptane to yield all the isomeric
alcohols, 2-heptanol being the main product. 78 Interestingly,
although the C-H bond strengths at C-2, C-3 and C-4 are similar, attack
at C-3 and C-4 is relatively smaller. Pretreatment of rats with
phenobarbital causes a four-fold increase in 2-, 3- and 4-hydroxylation,
but a relatively small increase in 1-hydroxylation. Benzpyrene
pretreatment causes a dramatic change in relative proportions of
different alcohols. Inhibition by carbon monoxide and metyrapone also
affects 1- and 2-hydroxylation differently. These results suggest that
more than one enzyme is involved in these reactions.
Alkylbenzenes provide options for pathways of biotransformation
alternative to the direct oxidation of side chain as in the case of
metabolism of alkanes. Thus the aromatic nucleus can be oxidized prior
to side chain hydroxylation, or it can be retained to give homologues of
alkane metabolism.
Kitagama79 showed that when suspensions of Pseudomonas
were exposed to toluene, enzymes for the oxidation of
toluene, benzyl alcohol, benzaldehyde, benzoate and catechol were
induced. This suggested that the methyl group of toluene was oxidised
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to benzoate prior to the formation of the ring-cleavage substrate,
catechol, presumably via the carboxyhydrodiol described later by Reiner
and Hegeman80 (Fig. 11).
Davey and Gibson81 looked into the bacterial metabolism of para
and meta xylene and found that various strains of Pseudomonas were
capable of performing successive single step oxidations of one methyl
group to form the respective toluic acids. The authors proposed the
pathways for conversion of toluic acid to the respective methyl
catechols similar to those shown in Figure 11.
The bacterial metabolism of p- and m-xylene may also be initiated
b d • ••d· f h · 1 82Y 1rect enzymat1c OX1at10n 0 t e aromat1c nuc eus.
The metabolism of ethylbenzene has been known as early as
1901. 83 Both the in vivo and in vitro oxidation of this
substrate by mammals as well as by microorgaznisms is well documented in
the literature.
Smith and coworkers84 discovered that an injection of ethyl
benzene into rabbits resulted in the urinary extraction of
1-phenylethanol. Since the formation of l-phenylethanol involves the
production of a chiral centre at carbon atom, the stereochemical
33
of the oxidation of became The
85
same authors that is hydroxylated in the
rabbit to both stereoisomers of l-phenylethanol in equal amounts,
whereas acetophenone is reduced to only one form, namely
(-) 1.
Figure 11. Pathways for Toluene metabolism
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85Many tentative mechanisms were proposed for the biological
hydroxylation of ethylbenzene. One possible path was via styrene and
acetophenone (Fig. 12 a). This was not of any significance, since
styrene does not yield 1-phenylethanol and acetophenone yields only the
(-) isomer. Then, another alternate path involving styrene epoxide was
proposed (Fig. 12 b). This proposal was mainly based on the fact that
styrene epoxide can be reduced chemically to 1-phenylethanol by lithium
aluminum hydride. However, styrene epoxide was not able to yield this
alcohol in the rabbit and therefore it was discarded as a possible
intermediate in the hydroxylation of ethylbenzene.
Since neither acetophenone nor styrene nor styrene epoxide were
intermediates in the formation of (+)-1-phenylethanol from ethylbenzene
85in vivo, the authors finally suggested a mechanism for the
reaction in which hydrogen is abstracted from the reactive ~-methylene
group by an enzyme, leaving a free radical or carbonium ion. This could
.
then combine with OH or OH , respectively, to form l-phenylethanol,
which would be expected to be racemic, since tervalent-carbon free
radicals are planar, and when a trivalent-covalent carbon atom carries a
positive charge, the ligands are coplanar (Fig. 13). They supported
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their by the fact that the oxidation of ethylbenzene to
1 by a free radical mechanism has been shown to occur in
purely chemical systems.
O th th h d · -1 • 86 d d - h h ·n e 0 er an, S1m1 ar exper1ments con ucte W1t epat1c
microsomal preparations were shown to be stereochemically selective,
Figure 12. Proposed mechanisms for Ethylbenzene hydroxylation in rats
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Figure 13. Proposed mechanisms for Ethylbenzene hydroxylation in rats
+OH
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producing about 80% R(+)- and 20% S(-)-l-phenylethanol. Other
studies87 with rat liver microsomes produced l-phenylethanol with
S(-) isomer as a major product (ca. 80%). Further investigations88
also revealed that S(-)-l-phenylethanol was the major product.
89Further research on ethylbenzene oxidation by microsomal
preparations from rat liver has been carried out in an atmosphere
containing oxygen-18. The oxygen-18 content of the l-phenyl alcohol
formed was estimated to be 68%, thus indicating that the hydroxylation
is a true oxygenation utilizing molecular oxygen and not oxygen from
water. That hydrogen from solvent is not involved was also shown.
Thus, when the incubation was carried out in deuterium oxide, no
isotopic hydrogen appeared in the enzymatic product.
The hydroxylation of 0( ,0( -d2-ethylbenzene (PhCD2CH3)
has also been investigated. 89 l-Phenylethanol formation from this
substrate was substantially slower due to a deuterium isotope effect
which was found to be kH/kD = 1.8. The resulting alcohol
retained one of the two deuterium atoms present in the starting
material. The optical purity of the alcohol formed was 81% R(+), which
was in good agreement with the value of 80% R(+) for alcohol obtained
from the incubation of unlabelled substrate. 86 These results
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suggested that the microsomal hydroxylation proceded by the
direct replacement of one of the O(-hydrogens of ethylbenzene by oxygen.
In the same study, incubation of optically active S(+)-d-ethylbenzene
with microsomal oxygenase system provided 91.7% R(+)-~
-d-l-phenylethanol with 86% retention of deuterium. From these results
it was clear that the microsomal hydroxylation of ethylbenzene occurs
with retention of configuration or, in other words, oxygenation occurs
by front side displacement.
The effect of microsomal enzyme inducing agents on the
stereochemical nature of hydroxylation has also been studied. 89 The
results with ethylbenzene and ~,O<-d2-ethylbenzeneas substrates
indicated that phenobarbital pretreatment substantially diminishes the
stereoselectivity ~f microsomal hydroxylation of substrates used in the
study. The authors proposed two possibilities for this effect, that
enzyme formed under the influence of phenobarbital differs qualitatively
from normal enzyme or there may be more than one enzyme catalyzing the
transformation and these enzymes may differ with respect to
stereoselectivity and sensitivity to phenobarbital induction.
In addition to l-phenylethanol, rats also oxidise ethylbenzene to
904-ethylphenol. Rat liver microsomes produce 4-ethylphenol and
912-ethylphenol. It seems probable that these phenolic metabolites
are formed by isomerization of the corresponding arene oxides. This
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of metabolism has already been discussed in detail in a previous
In contrast, few published data are available pertaining to the
metabolism of ethylbenzene by microorganisms that can use this
hydrocarbon as its sole source of carbon and energy. Davis and
92Raymond grew a Nocardia species on octadecane in the presence of
ethylbenzene. Under these conditions, the aromatic hydrocarbon was
converted to phenylacetic acid which was resistant to further
d d - A P d - 93 -d- d- h lbegra at1on. ·seu omonas stra1n OX11zes p- 1et y enzene
exclusively to the monocarboxylic acid, p-ethylphenylacetic acid.
Deuterium labelled p-diethy1benzenes show an isotope effect of
kH/kD = 1.7 (Fig. 14 A). Retention of the deuterium on the
carbon (Fig. 14 B) indicated that the major pathway of oxidation
involves direct terminal oxidation of the side chain and not
dehydrogenation followed by hydration.
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The oxidation of ethylbenzene by Pseudomonas was reported
by Gibson et al 94 and a detailed study was made. The data
obtained indicated that P. putida metabolizes ethylbenzene by pathway
A or B (Fig. 15). Pathway A resulted in the isolation of
3-ethylcatechol. A minor dio1 product of ethylbenzene oxidation (about
2%), which was more polar than the diol described, was identified from
pathway B. This metabolite had also been oxidized at the benzylic
carbon providing
(+)-cis-3-)1'-hydroxyethyl)-3,5-cyclohexadiene-1,2-dio1. There was
evidence to demonstrate that this compound was formed by the
stereose1ective oxidation of ethy1benzene to (+)
followed by dioxygenation of the aromatic ring, since the ethylbenzene
dio1 did not serve as a precursor of this product whereas
1-pheny1ethano1 formed the same product by the same organism. Reaction
sequence B initiated by benzylic oxidation appeared to be of minor
Figure 14. Metabolic routes of Deuterium labelled p-Diethylbenzenes
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Figure 15. Reaction sequences utilized by ~ putida to oxidize
Ethylbenzene
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importance to the organism. All the compounds except those in brackets
were isolated. The authors, however, proposed their formation based on
the isolation of the other componds.
Thus one wouldvia
Aliphatic hydroxylation reactions are generally considered to
I h ·l· · h· 95e ectrop 1 1C react10n mecan1sms.proceed
expect substituent electronic effects upon the rate of aromatic
side-chain oxidations at the o(position. However, studies have shown
that K and V of such hydroxylation reactions showed little
m max
or no dependence upon electronic differences in the substituents. The
rate of hydroxylation by cytochrome P-450 is probably relatively fas-t
compared with other steps in the oxidation process. Thus substituents
may significantly alter the rate of oxidation without this being
reflected in the rate of product formation. These problems have been
overcome by the use of substituted 1,3-diphenylpropanes to study
substituent effects upon hydroxylation at the benzylic carbon
96
atom. Such compounds have the advantage that there is an
intramolecular competition for hydroxylation at the two benzylic
positions (Fig. 16). The ratio of the rates of hydroxylation at the
benzylic positions kH:~ may, therefore, be determined by
measuring the ratio of two products in the reaction mixture without
reference to the absolute rate of hydroxylation. Problems arising from
steric hindrance may be minimized selection of appropriate
substitutents. The compounds used were R = H, F, CH3 and CF3 •
With fluorine and substituent, 70% and 95%
Figure 16& Hydroxylation of .substituted 1~3-Diphenylpropanes
R
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of the product was hydroxylated at the benzylic carbon of the
nonsubstituted benzene ring. Methyl substitution did not result in
selective hydroxylation of either benzylic position. When CF3 is
compared with CH3 and F is compared with H (comparisons which
minimize the effects of steric hindrance), it is apparent that the
position of hydroxylation is oriented away from electron withdrawing
groups. This demonstrates that aromatic side-chain hydroxylation occurs
by an electrophilic mechanism.
The same authors97 have studied the isotope effect of
hydroxylation reactions using 1,3-diphenyl-[1,1-d2]-propane which is
deuterated at one of the benzylic positions (Fig. 16). This molecule
has the advantage that there is an intramolecular competition for
hydroxylation at the two benzylic positions. Thus the isotope effect
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by determination of the ratio of
the fully deuterated product to that in which one deuterium atom has
been replaced by a hydroxyl group (Fig. 17). The results from
incubation with rat liver microsomes gave a value of kH/kn = 11,
which is much greater than previously reported values for benzylic
hydroxylations by microsomal monoxygenases. On the basis of these
results, the authors suggested a radical abstraction-recombination as a
mechanism for aliphatic hydroxylation reactions.
In a recent paper, McIntire et al 98 have described enzymic
hydroxylation of p-ethylphenol by highly p-cresolmethyl
Figure 17. Microsomal hydroxylation reaction
of 1,3-Diphenyl-[1,1-dZ]propane
H HOD
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hydroxylase and Pseudomonas which gave optically active
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l-(p-hydroxyphenyl)ethanol. The products were transformed into the
phenolic methyl ethers and shown to contain enantiomeric excesses of
31.2% and 39 0%, respectively, of the (S)-(-)-isomer. The
stereochemistry of the reaction catalysed by p-cresolmethyl hydroxylase
is discussed in terms of three distinct and potentially stereospecific
steps occurring at the active site of the enzyme (Fig. 18), but since
the enzyme is not a monooxygenase, the relevance of this finding to the
mode of action of cytochrome P-450 dependent monooxygenases is unclear
and, therefore, not being discussed here in detail. The
stereoselectivity of product formation by P. putida was not commented
upon.
In addition to ethylbenzene, propyl and butyl benzenes have also
been to be metabolized by a variety of bacterial strains
· 1 d · h · 1 b b 99,1001S0 ate W1t 1sopropy enzene as cara on source.
Apart from the formation of 1-phenylethanol, the oxidation of
ethylbenzene by rat liver microsomes also produced 4-hydroxyethylbenzene
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and 2-hydroxyethylbenzene. Now, it is apparent from the
literature that the ethylbenzene molecule possesses several different
positions that are susceptible to oxidation. The site of the initial
reaction varies with the source and specifici of the enzyme system
involved.
Considerable information is available on oxidation of ethylbenzene
mammalian hepatic microsomes but at this time there have been no
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Figure 18. Reactions catalysed by p-Cresolmethyl hydroxylase
* Hypothetical intermediate
OH
(f)
+H
p-Ethylphenol
"1<Quinone methide
l-(p-hydroxyphenyl) ethanol
p-Hydroxyacetophenone
detailed reports on the metabolism of ethylbenzene by cytochrome P-450
dependent monoxygenase in a
Recent studies102 undertaken in our laboratory have
demonstrated that a series of para-substituted alkyl aryl sulphides have
been transformed stereoselectively to the corresponding sulphoxides by
incubation with the fungus Mortierella isabellina. The enantiomeric
purity of the products was dependent on the electronic nature of the
para substituent. Since the sulphur oxidation of alkyl aryl sulphides
and benzylic hydroxylation at saturated carbon are believed to have
electrophilic character,95 although their connection has yet to be
established, if the same monooxygenase system is carrying out both the
oxidations, then it may be proposed that ethylbenzene and its para
substituted analogs can be transformed to optically active alcohols and
stereoselectivity will be susceptible to electron withdrawing or
donating nature of para substituents.
The present study describes an analysis of metabolites formed from
alkylbenzenes by Mortierella isabellina NRRL 1757. In addition to
the product formation, steric and electronic effects of sbustitution at
the para position of the aromatic ring on the degree of enantiomeric
enrichment of the resultant chiral alcohols are discussed. To our
knowledge, this seems to be the first study which represents the
transformation to optically active alcohol
cytochrome P-450 dependent enzyme.
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PART THREE
Microbial Reduction of Ketones
50
P ede 85 hr1mary stu 1es on t e in vivo reduction of acetophenone
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to only one stereoisomer, i.e., (-)-l-phenylethanol have established
that an enzyme which mediates the stereospecific reduction of
acetophenone is also present along with the enzyme which catalyses the
nonspecific hydroxylation of ethylbenzene to racemic l-phenylethanol in
rabbit body.
Culp and McMahon103 have described the reduction of
acetophenone and its para substituted analogs by an enzyme, aromatic
aldehyde ketone reductase. A-K reductase, however, does not catalyze
the reverse reaction under the experimental conditions used. The effect
of ring substitution on the rate of reduction was of interest.
Electron-withdarawing groups greatly enhance the rate, while the
electron donating group enforces a reduced rate.
104A-K reductases are usually NADPH dependent enzymes found in
the cytoplasmic fraction of the cell and have very broad substrate
specificity.
The reduction of a series of aliphatic and aromatic ketones has
been shown to be catalysed by enzymes in rat liver which differ in
cofactor requirements from LAD. lOS The cytosol is the
site for reductions. Substrates in which at least one aromatic is
adjacent to the carbonyl group are reduced to alcohols in NADPH
dependent reactions. Aliphatic ketones are reduced ly well in the
presence of NADH and NADPH. Acetophenone reductase was not enhanced by
pretreatment of rats with phenobarbital. The enzyme responsible for the
reduction of aromatic ketones was thought to be probably identical with
that described by Culp and McMahon. B5
Reductions of ketones106 are often catalysed by the
oxidoreductases that oxidise alcohols. Reveresibility can be
demonstrated by using the appropriate substrate and cofactor. Cyclic
ketones are reduced by an enzyme present in human liver. The enzyme
activity is located in the cytosol, and is not found in the microsomal
fraction; it utilizes NADPH more effectively than NADH. The reaction
occurs in the presence and absence of oxygen. It is readily reversible,
alcohol is oxidized to ketone in the presence of crude enzyme
preparation and NADP. The pH optimum for the reverse reaction is higher
than that for the forward reaction, but it is not known whether the same
enzyme catalyses both (Fig. 19).
Cervinka and Hubl07 have shown the stereoselective reduction of
tro and p-methoxy acetophenone using yeast, Saccharomyces
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cerevisiae. In both the cases, an excess of laevorotary alcohols was
obtained; the two alcohols were assigned S configurations.
A detailed discussion of these reductions is beyond the scope of
this thesis, however, enzyme catalyzed reduction of ketones, producing
chiral alcohols has been documented. lOB
This s deals with the stereoselective reduction of carbonyl
group present in acetophenone, 0<, 0( ,0< -trifluoroacetophenone and
p-ethylacetophenone to the corresponding chiral alcohols, using
Figure 19. Microbial reduction of Ketones
a
+NADPH +NADP
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isabellina NRRL 1757. This metabolism may be of
considerable importance to synthetic organic chemist as it provides a
54
convenient pathway to produce chiral alcohols in high optical
good chemical yield which may otherwise be difficult to obtain.
ty and
PART FOUR
Cytochrome P-450 : A Unified View
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Cytochrome P-450 is the collective name for a distinct group of
protoheme containing proteins which show a characteristic absorption
band at around 450 nm in the carbon monoxide difference spectrum of
dithionite reduced samples.
Cytochrome P-450 was first described in mammalian liver microsomes
and was originally thought to be occurring only in restricted biological
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systems. However, subsequent studies have revealed that heme
proteins with similar spectral properties are distributed very widely in
nature, they can be detected in almost all forms of life. 59 ,95 In
mammals, cytochrome P-450's are found at varying concentration in
microsomes (endoplasmic reticulum) of the liver, kidney, small
intestine, lung, adrenal cortex, skin, testes, placenta and several
other tissues. The enzyme system that has received most of the
attention is that of mitochondria and liver microsomes. Cytochrome
P-450's have also been detected in bacteria, yeasts and fungi. These
enzymes exist in both soluble and membrane bound forms.
These enzymes, which incorporate one molecule of molecular oxygen
into the substrate, are classified monooxygenases and carry out
"d" " h h " h" h b 1 109OX1 at10ns W1t t e st01C 10metry sown e ow.
The specificity of this monooxygenase is also different than that
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Besides
of most enzyme systems, which are usually specific for one group of
substrates. This enzyme system is capable of catalyzing the oxidation
of a wide variety of compounds. Not only is it able to react with
polycyclic aromatic hydrocarbons and steroids,95,110 but also with
111
acids, alkanes, drugs and a variety of foreign compounds.
It appears to be one of the most versatile catalysts available for many
react1e ons110 ,112 such h d 1 t e d ed t eas y roxy a 10n an epox1 a 1on.
113 114these main functions, P-450 also catalyzes ' su1phoxidation, N-
and O-demethylation, deamination, N-oxidation and other reactionsl15
of a range of different substrate types. Because of the diversity of
substrates and the variety of transformations that these enzymes
execute, this family of cytochromes has attracted the attention of
several groups in many fields including organic, inorganic and
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biochemis , pharmacology, bacteriology, toxicology and oncology.
Interest in the latter two fields has been particularly great because of
the ability of these enzymes to metabolize rather inert compounds to
electrophi1ic products that can bind irreversibly to cellular
macromolecules and thus resulting to the ultimate development of toxic
or tumorigenic lesions. This aspect of the cytochrome's function has
been discussed in a previous section. In addition to its biological
significance, this enzyme now constitutes a formidable synthetic
arsenal. Cytochrome P-450 is capable of directly introducing a hydroxy
group into an organic molecule by performing the direct conversion of
carbon-hydrogen bond to carbon-hydroxyl with defined regio- and
efe e 95stereospec1 1C1ty. Thus, cytochrome P-450 is also a t n
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which can be explored by the synthetic organic chemist to produce many
compounds which are otherwise inaccessible to produce by conventional
chemical means.
The reason for the wide range of substrate specificity is not quite
understood, but this has been partly attributed to multiple forms of
cytochrome P-450 and was supported by the observation of variable
activities in animals which were treated with different P-450 inducing
agents. The most common inducing agents used are phenobarbital and
3-methylcholanthrene.
Since its discovery over two decades ago, cytochrome P-450 has been
an object of intensive research by both organic and biochemists, and a
1 f d h b ·1 d 59arge amount 0 ata as een comp1 e •
In attempting to understand how the enzyme performs the reactions,
an accurate description of its structure and how the active site works
is required.
The problem with working with a cytochrome P-450 system is that it
is difficult to isolate and purify a soluble form of the enzyme. This
is why the enzyme preparation from camphor grown Pseudomonas
is important; it is soluble and is thus most precisely defined
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cytochorme P-450 and has been obtained in a crystaline form.
Much of the mechanistic work on this class of enzymes has been performed
using soluble enzymes obtained from camphor hydroxylating enzyme of P.
59 117
, or on enzymes of mammalian origin, but the available
evidence suggests that all cytochrome P-450 monooxygenases function by a
., 01 h 0 59S1m1 ar mec an1sm.
The actual structure of cytochrome P-450 can be divided into two
parts: a protein body, the "apoenzyme" and an iron heme in the form of
iron protoporphyrin protosthetic group, the "cofactor". A protoheme
group containing iron(III) in the resting state of the enzyme, is
coordinated to a macrocyclic tetrapyrrole ring (Fig. 20).95 The
pyrro1e nitrogens of this ring make up four ligands to the iron in
equatorial positions, which leaves the two axial positions to be filled
by other ligands. These two ligands are provided by the protein; one of
these is a cysteine sulphide ion, while the other, which is displaced
oxygen during the catalytic cycle, is currently unidentified but may be
imidazole nitrogen of a histidine residue. This is how the
catalytically active heme cofactor is bound to the apoenzyme.
The role of apoenzyme and cofactors may be distinguished as
follows: the apoenzyme is responsible for the binding of the substrate;
and cofactors are responsible for the binding of oxygen, its activation
and delivery to the substrate of the oxidizing species. The apoenzyme
has at least three binding sites for the substrates so that the
substrate can be bound in a stereospecific manner and this is how it
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controls the substrate regio- and stereo-specifici of hydroxylation
reaction. There are different types of cytochrome P-450 which have
different protein (i.e., the amino acid sequence) of the
enzyme, and thus differ in bonding of substrate,118,119 and
Figure 20: Protoheme group of Cytochrome P-450
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eaOH eaOH
this variation is largely responsible for wide range of the substrate
efe •• d f e 95spec1 1c1t1es an t ormat10n.
The multiple forms of cytochrome P-450 function with different
substrate, regio- and stereo-specificities, but the available data from
mammalian systems suggest that all are dependent on the same
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120 121
cofac tors. ' The close similarity between reactions performed
by mammalian and fungal systems as discussed by Smith and Rosazza122
suggests that a parallel state of affairs may also exist between the two
at the enzymic level. The binding and the activation of oxygen, as well
as its transfer to the substrate is described in the catalytic cycle of
cytochrome P-450 illustrated in Figure 21. The cycle has been mainly
deduced from studies of the soluble cytochrome P-450 • The first
cam
step, substrate binding, is necessary before the enzyme can bind oxygen
or accept any reducing equivalents. The substrate does not bind
directly to the heme unit, but is presumably bound by the apoprotein in
1 • • h f 95c ose proX1m1ty to t e co actor. When cytochrome P-450 is in its
resting state, i.e., not bound to substrate or oxygen, the enzyme is in
the iron(III) state in a low spin form. 123 In this case, the 5d
electrons distribute themselves in the three low lying dxy, dyz and dxz
orbitals. Since there are no electrons in the Eg orbitals, the
2 2dx -y and orbitals are empty and this spin state is
more compact. Therefore the six ligands around the iron atom are
arranged into an octahedral complex (Fig. 22). Substrate binding the
cytochrome P-450 can promote a change of the iron(III) from low spin to
Figure 21. The catalytic cycle of Cytochrome P-450 dependent
monooxygenases. (8 = substrate)
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Figure 22: Spin transition in Cytochrome P-450
Substrate binding
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Low spin
High spin
a high spin electronic configuration. In the high spin state, one
2 2
electron on iron enters the dx -y orbital. The four lobes of
this orbital occupy the same space as that occupied by the lone of
electrons on the porphyrin nitrogens. Therefore, when an electron
enters this orbital, the actual diameter of the iron atom is increased.
It then no longer is capable of resting in the cavity of the planar
124porphyrin ring but is above the plane. A change in coordination
number from six to five is believed to accompany this transformation,
and as a result the interaction with the sixth unidentified ligand is
broken.
In the next step of the catalytic cycle, the cytochrome substrate
complex undergoes a one electron reduction. This electron is ultimately
derived from the oxidation of Kreb's cycle intermediates and is
transferred to the cytochrome P-450 via a complex array of cofactors
(Fig. 23). The first cofactor, NAD(P)H, is provided by the oxidation of
Kreb's cycle acids. It passes its reducing equivalent to a flavin
cofactor, FAD. The product of this initial transfer, FADH2, passes
only one electron to an iron-sulphur protein (ferredoxin)_ This leaves
the flavin cofactor at the level of FADH-. Finally, the iron
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centers of ferredoxin carry out the actual reduction of the iron
center of cytochrome P-450. This sequence of cofactors is applicable
for electron transfer in the case of camphor grown ~ , while
Figure 23. Reduction of Cytochrome P-450
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in hepatic microsomal systems the iron-sulphur protein is replaced by
cytochrome b5 •
125 In either case, these cofactors use the
reducing equivalents generated by the Kreb's cycle to reduce the
prosthetic group of cytochrome P-450. The reduced heme iron is then
ready to bind and activate oxygen.
The activation of oxygen is initiated by its binding to reduced
cytochrome P-450. Because the oxygen is a good electron acceptor, this
step is quite rapid.
The binding of molecular oxygen to the porphyrin iron results in
•the formation of iron-oxy complex [SH-Fe(III)-02]. The system is
now capable of receiving a second electron which is provided by
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FADH· bringing the flavin cofactor back to the ful oxidized state,
FAD (Fig. 23). The product of this second reduction is an iron-peroxo
complex, [SH-Fe(III)-O-O-]. At this stage, the enzyme complex
becomes the active species which dissociates readily to product and
water and regenerates the iron in free state. During this process, one
atom of molecular oxygen is given to a proton to produce the water
molecule. After the addition of the second electron, the mechanism
becomes unclear because of this rapid dissociation. At the present time
there is no suitable for the active oxygen species
cytochrome P-450. Most of the data obtained regarding this species has
resulted from the studies of oxidation of organic substrates and from
chemical models of this enzyme.
Although cytochrome P-450 monooxygenases from different
sources show differences in electron-transport cofactor requirements,
the available data suggest that overall features of the catalytic cycle
of these enzymes are largely independent of the source. 59
It has always been assumed that no specific activation of the C-H
bond in the substrate is provided by the enzyme. The position of
hydroxylation is controlled by the geometrical nature of the active
site. However, not all C-H bonds of a substrate are equally reactive
towards hydroxylation. 95
The nature of the enzymically activated oxidising species is now
clear, and factors which can control the binding are understood. It is
now possible to examine the actual mechanism of hydroxylation. This
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aspect of the hydroxylation process is not fully understood.
However, in recent years the route by which the activated oxygen complex
of figure 21 reacts with a C-H bond has been the subject of extensive
investigations. Two favoured mechanistic pathways have been proposed
(Fig. 24), a concerted insertion of electrophilic oxygen (UOxeneU) into
a C-H bond of substrate (Fig. 24, path A)126 and a radical
abstraction-recombination mechanism (Fig. 24, path B).127 Evidences
for both are available but which one of these mechanisms is correct has
still not been resolved. This lack of agreement is well illustrated by
a recent study involving the oxidation of ethanol by cytochrome P-450,
which both the mechanisms. 128 The authors proposed that
both pathways must be correct but which one will be dominant in any
particular case would be determined by the environment of the enzyme.
For example, in the presence of hydroxyl radical scavenger molecules
(e.g., DMSO, benzoate), the concerted mechanism would work.
Therefore, in special circumstances both pathways
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Figure 24. Possible routes for hydroxylation at saturated carbon
4+ .•Fe-a-
II ..
• •
4+ •. r:\ /Fe- 0-> ~H~-C-====:J
B
~+ ••~'-4Q.
A
Therefore, if the enzymic process
may operate.
In most cases experimental data favours only one mechanism for
cytochrome P-450 hydroxylation. The oxene mechanism of hydroxylation
(Fig. 24, path A) has been accepted as being the most consistent with
the results obtained in various studies. First, cytochrome P-450
catalysed hydroxylation proceeds with retention of configuration at
carbon center. 129 If substrate bonds were broken and free radicals
formed, some type of rearrangement or racemization could occur.
Secondly, a closely related reaction, epoxidation, is also carried out
b h P 450 d d 130 -1-· hY cytoc rome - epen ent monooxygenases ut1 1z1ng t e same
- d b- d- · 131 Th b h h d 1 - dact1ve an 1n 1ng s1tes. us ot y roxy at10n an
epoxidation must proceed by essentially the same pathway. The
epoxidation of alkanes by peroxyacid has been shown to occur via a
d - · h· 132concerte 1nsert10n mec an1sm.
is identical to the chemical pathway, the concerted mechanism must be
correct.
Further evidence for the concerted mechanism came from the studies
with aromatic systems. Hydroxylation of these compounds proceeds with
the intramolecular migration of the substituent from the position where
the hydroxy group is induced, to either adjacent ortho positions. This
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phenomenon is called "NIH (Fig. 2).14 The observation that
the non-enzymatic isomerization of arene oxides showed rearrangements
compatible with the migrations that take place during NIH shift led to
the proposal that an intermediate arene oxide might be involved in these
133 134 135
reactions. Jerina et ~ , reported the isolation of
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1, oxide from the incubation of with rat liver
microsomes. The presence of this arene oxide intermediate was explained
by an addition of an oxene to a carbon-carbon double bond.
136Dalton and co-workers examined the cytochrome P-450
catalyzed hydroxylation of cyclopropane and methylcyclopropane using
Methylococcus capsulatus as the enzyme source. No rearrangement
products were detected, supporting the electrophilic insertion
mechanism. Cyclopropanol and cyclopropyl methanol were observed as the
only metabolic products from cyclopropane and methylcyclopropane,
respectively. If any electron deficient species such as a cyclopropyl
carbocation or a cyclopropylmethyl radical were formed, oxidation could
have led to the formation of allyl alcohol or but-3-en-1-ol. These
products were not observed, indicating that free charged or radical
intermediates were not involved (Fig. 25).
All these results, plus the fact that cytochrome P-450 catalysed
hydroxylation proceeds with a very low intermolecular isotope effect
89(generally kH/kD < 2) have been interpreted as consistent
with an insertion mechanism (Fig. 24, path A).
However extensive investigations of hydroxylation mechanism also
lend credence to the nonconcerted radical abstraction pathway B of Fig.
24.
Figure 25. Hydroxylation of Cyclopropane and Methylcyclopropane
by ~ capsulatus
OH
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The formation of the bridged
The first positive indication that hydroxylation may prodeed via
radical intermediates came from a study of the metabolism of the
· t·· d D· ld· · 1 137lusec lCl e le rln ln mamma s.
metabolite has been explained by the mechanism which involves a
transannular reaction of the radical intermediate (Fig. 26).
Further evidence for radical intermediates has been provided by
138
experiments performed by Groves and coworkers. These studies
showed that the hydroxylation of norbornane by a liver cytochrome P-450
system affords exo and endo-2-norborneol (Fig. 27, A and B), in a
ratio of 3.4:1. The ratio of these products dropped to 0.76:1 when
~ , ~ , ~ , ~ -2,3,5,6-tetradeuteronorbornane was hydroxylated.
Analysis of the mass spectra of the products obtained from deuterated
substrate revealed that 25% of the exo-norborneol contained four
deuterium atoms whereas 9% of the exo-norborneol contained three
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deuterium atoms These results indicate a very large isotope effect
(kH!kn = 11.5 ± 1) and a significant amount of epimerization for
the hydroxylation of norbornane by cytochrome P-450. On the basis of
these results, the authors suggested a free radical mechanism initiated
by hydrogen abstraction.
Since these early findings, the studies supporting the free radical
mechanism have been growing rapidly.
139In a recent study, a mechanism involving a free radical
intermediate has been proposed for the hydroxylation of camphor at C-5
giving 5-exo-camphor, by cytochrome P-450 system of camphor grown ~
It was shown that camphor analogues containing deuterium at
ei ther the 5- exo or 5- endo
Figure 26. Rearrangement during Dieldrin metabolism
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Figure 27. Hydroxylation of Norbornane by Liver Cytochrome P-450
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5-exo-hydroxycamphor (Fig. 28). This reaction occurred with a
substantial loss of stereochemis at carbon 5 of camphor since the
product 5-exo-hydroxycamphor retains a substantial fraction of deuterium
when formed from either camphor 5-exo-d1 or camphor-5-endo-d1 •
Such a loss in stereochemistry was attributed to the partial
epimerization of the substrate radical in the active site following
hydrogen abstraction. A sizable intramolecular isotope effect was also
observed, which supports the stepwise mechanism.
These studies are convincing in favour of a stepwise mechanism
involving a free radical intermediate. However, there is some evidence
which argues against this mechanism. The retention of configuration has
always been used as the proof of a concerted mechanism. This
observation can be explained as follows. Since the monooxygenase
reactions of cytochrome P-450 are enzymic, once the substrate reacts
with the enzyme it is presumably held in place by the configuration of
the active site. If substrate bonds are broken during catalytic cycle
of the enzyme, then any change in configuration may be hampered, and
h · f fe e S de 140 htus retent10n 0 con 19urat10n may occur. ome stu 1es ave
indicated that the retention of configuration observed in the enzymic
reaction is not inconsistant with a stepwise mechanism. Rapid collapse
of the intermediate radical formed in the enzymic reaction could also
account for this observation. This means that failure to observe
75
might be due to a relatively short living radical
intermediate which reacts with the oxidising species before a complete
76
Figure 28. Hydroxylation of camphor by Cytochrome P-450
cam
H
o
H
o
o
D~
o
0
0
H~0 0
0 •~
0
OH
0
\0 OHH
loss of stereochemis can take place.
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The only inconsistency left is that of the intermolecular isotope
effect (kH/kD < 2.0); this should be larger if a C-H bond is
broken in the transition state. This aspect has also been studied quite
It has been proposed that low kinetic isotope effect is a
result of various factors. The rate determining step in the cytochrome
P-450 cycle (Fig. 21) has been reported as the addition of the second
d · · 1 141 d h d·· f hre uC1ng equ1va ent an t e ecompos1t10n 0 t e
142P-450-substrate-oxygen complex to products. It is not clear to
what extent the latter steps of the catalytic cycle (Fig. 21) are
kinetically dis and this has hampered a clear interpretation of
the intermolecular isotope effects observed for hydroxylation. In most
cases, such effects have been determined by product composition analysis
following competitive hydroxylation of both labelled and unlabelled
substrates. It is not unreasonable to assume in such a system the
possible existence of isotope effects in substrate binding and other non
143
rate-limiting steps. In view of these complicating factors, the
intramolecular isotope effects are now considered more important than
intermolecular effects in providing the data for mechanistic studies.
In cases where both inter and intramolecular isotope effects have been
determined for the same substrate, the differences are
144
clear. The intramolecular isotope effects are typically large
(k /k = 10_11)97,138 and are consistent with a radical
H D
abstraction-recombination process.
et
There has also been work done with cytochrome P-450 models and the
results obtained were interpreted in favour of a stepwise mechanism.
_ 145-147Work with iron porphyr1n models also suggested the formation
f f d - 1 d - th t b 1- th Another study148o ree ra 1ca s ur1ng e me a 0 1C pa way.
using iron porphyrin/iodosyl benzene catalytic system to perform
hydroxylation of unactivated alkanes led to the observation of large
kinetic isotope effect (kH/kn = 12.9 ± 1). An isotope effect of
this magnitude clearly supports the radical mechanism.
The substrates discussed above are by no means the only example to
confirm the operation of stepwise mechanism involving the free radical
intermediate in the cytochrome P-450 catalyzed hydroxylations. Holland
1 110,112 h f d h d 1· - - ha ave per orme y roxy at10n exper1ments W1t
steroidal systems using Rhizopus arrhizus; their results clearly
support a stepwise mechanism.
A closely related reaction, also carried out by cytochrome P-450
130dependent monooxygenases, is the epoxidation of olefinic
substrates. This reaction may proceed via one of the mechanisms of
Figure 29, analogous to the corresponding concerted (path A) or stepwise
(path B) routes of Figure 24. Evidence for both is
avai1ab1e,130,146 but the work of Holland and coworkers110 ,112
lends credence to the stepwise (path B) rather than concerted ( A)
mechanism of Figure 29.
Therefore, though the majority of the recent studies support the
stepwise mechaniasms for cytochrome P-450 cata1ysed oxidations, these do
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Figure 29. Possible routes for epoxidation at olefinic carbon
4+ .•Fe---O·
• •
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not necessarily exclude the concerted mechanism.
One final piece of information regarding cytochrome P-450,
pertaining to its role in substrate sulphoxidation is that this system
is capable of converting sulphides into sulphoxides and these to a
certain extent into sulphones. 102 ,114,149 A mechanism has been
proposed whose rate determining step involves an electron transfer from
a divalent sulphide to the activated iron-oxygen species and a radical
cation species is the involved intermediate (Fig. 30).149,150
I h · 114 1 h -d - f · fn ot er exper1ments, su p OX1at10n 0 a ser1es 0
substituted methylphenyl and benzylmethyl sulphides have been
investigated. The results thus obtained revealed that the oxygen
incorporated in the enzymic reaction is derived exclusively from the
atmosphere and not from water. The data obtained in these experiments
were interpreted in terms of a mechanism of oxidation at sulphur
80
involving an ~~,,_&,~~~ic attack on the sulphide sulphur by the
activated iron-oxygen complex, followed by conversion of the resulting
sulphur cation to sulphoxide.
The study is concerned with transformations catalysed by
cytochrome P-450. A variety of fungi known to use cytochrome P-450
dependent monooxygenases have been used.
The first of this s deals primari with the metabolism of
common environmental
microorganisms.
In the second
lutants by cytochrome P-450 containing
the mechanism of cytochrome P-450 catalysed
Figure 30. Proposed mechanism for sulphoxidation by Cytochrome P-450
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hydroxylations has been investigated. Ethylbenzene with a variety of
electron donating and withdrawing substituents at para position has been
used as a substrate. If the hydroxylation proceeds by concerted
mechanism (Fig. 24 ,then there should be no effect of para
substituent on the optical purity of product formed, but if stepwise
mechanism (Fig. 24 B) is operative and a free radical cation is formed
as an intermediate, then the enantiomeric excess may depend upon the
stability of intermediate which ultimately depends upon the electronic
character of the para substituent. In this way it is hoped that some
insight of the mechanism of cytochrome P-450 catalysed hydroxylation
could be obtained.
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Apparatus, Material, and Methods
84
Melting points were determined on a GallenKamp and are
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uncorrected. Ultraviolet spectra were obtained on a Hitachi
Perkin-Elmer 124 spectrophotometer with HPLC grade methanol as solvent
and reference. Infrared spectra were recorded on a Analect FX6260 FT IR
spectrophotometer. Proton NMR spectra were recorded at 60 MHz with a
Bruker WP-60 FT NMR spectrometer or at 80 MHz on a Bruker WP-80 CW NMR
spectrometer using CDCl3 or acetone-d6 as solvent and TMS as
13internal standard. C NMR spectra were obtained at 15.18 MHz with
a Bruker WP-60 FT NMR spectrometer or at 100 MHz with a Bruker WH-400 FT
NMR spectrometer or at 20.115 MHz with Bruker WM-80 FT NMR spectrometer
using CDCl3 as a solvent and TMS as internal standard unless
otherwise stated. NMR spectra were recorded at 56 MHz with a
Bruker WP-60 FT NMR spectrometer using CCl4 as solvent and CFCl3
as internal standard. Enantiomeric ratios were determind in CCl4 in
the presence of (tris[3-(heptafluoropropylhydroxymethylene)- ~
-camphorato]europium(III). Mass spectra were obtained with an AEI MS30
double focusing mass spectrometer interfaced to a Kratos DS-55 data
system. EI mass spectra were obtained at 70 eV with a 4K accelerating
vol Column chromatography was on Merk silica (60-200
mash), and thin layer chromatography on Merk silica gel 60F-254 (0.2 mm
thick). The plates were examined under UV light or were sprayed with a
80% concentrated sulfuric acid/ethanol solution or with a 2% (w/v)
methanolic solution of 2,6-dichloroquinone-4-chlorimide (Gibb's
regent) and developed at 110°C. Preparative tlc was performed on Merk
silica gel F254 (2.0 mm thick) and was examined under UV light. Optical
rotations were determined with a Perkin-Elmer 241 MC polarimeter using a
1 dm cell and 95% ethanol as a solvent. The incubation flasks were kept
on a New Brunswick rotary shaker (23-25°C, 150-250 rpm).
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Stock cultures of *Cunninghamella elegans ATCC 26269 were
maintained on potato dextrose agar slopes. Rhizopus arrhizus ATCC
11145 and Mortierella isabellina NRRL 1757 were maintained on 4% malt
agar slopes.
Elemental analysis were performed by Guelph Chemical Laboratories
Ltd., Guelph, Onto
* This was the name of fungi when the work des'cribed herein was started
but after one year it changed to ~~~~~~=l~a echinulata var.
However, in the text of this thesis the fungi is refered to
by its old name.
PART ONE
Synthesis of Substrates
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Most of the compounds used in the present study were either
obtained commercially or were generously given by some one, so their
synthesis will not be discussed here, only their spectral and physical
data are given here. However, appendix I contains the information in
the form of a chart which describes the source from which they were
obtained and in some cases the literature reference of their
preparation.
Dibenzothiophene , !
M.P. 97-100 oC. Its l H NMR spectrum included signals at b:7.3
(2H,m,C-2,3,6,&7H), 7.75 (2H,m,C-4&5H), and 8.05 (2H,m,C-l&8H). UV
spectrum, A at 257, 282, 310, and 325 nm. Mass spectral data,
max
m/e (%): 184 (100,M+·), 152 (11), 139 (22), 113 (4), 95 (5), 79 (4),
88
74 (5), 69 (7). 13The C NMR spectral data is listed in Table 2.
Dibenzopyrrole (Carbazole) , !
1 151M.P. 242-243°C. The H NMR (acetone-d6) included
peaks at &: 7.0-7.5 (6H,m,C-2,3,4,5,6,&7H), 8.05
(2H,d, ,2=7.5Hz,C-l&8),and 10.25 (lH,s,br,NH). Mass spectral data,
m/e (%): 167 (100,M+·), 166 (18), 140 (11), 139 (14), 113 (3), 87
(3), 83 (6), 75 (3), 63 (6).
Table 2.
13The C NMR spectral data is given in
Fluorene , 1
M.P. 116-117°C. The l H NMR included peaks at S: 3.9 (2H,s),
7.3 (4H,m), 7.5 (2H,m), and 7.75 (2H,m). Mass spectral data, m/e (%):
165 (100,M+·), 163 (16), 139 (16), 115 (17), 87 (6), 82 (9), 81 (5),
74 (5). The 13C NMR spectral data is listed in Table 2.
9-Fluorenone , i
M.P. 82-83°C. The l H NMR contained peaks at S: 7.25 (2H,m),
7.6 (2H,m). Infrared spectrum, V : 1717 cm-1 (cyclic ketone),
max
and 3012 cm-1 (unsaturated C=C). The mass spectral data, m/e (%):
180 (100,M+·), 152 (30), 151 (16), 150 (11), 126 (6), 76 (18), 75
(6), 63 (7). The l3C NMR spectrum is assigned in Table 2.
Acridine, 1.
M.P. 111°C. The l H NMR included peaks at S: 7.55 (2H,m), 7.7
(2H,m), 8.0 (2H,d), 8.2 (2H,d), 8.75 (2H,s). Mass spectral data, m/e
(%): 179 (100,M+·), 178 (28), 153 (26), 152 (11), 151 (10), 126 (5),
89 (11), 75 (8). The 13C NMR spectral data is given in Table 2.
Phenanthridine , 6
M.P.l05-l06°C. The l H NMR included peaks at S: 7.4-8.05
(5H,m), 8.1-8.6 (3H,m), and 8.27 (lH,s). Mass spectral data, m/e (%):
179 (100,+·), 178 (21), 177 (10), 151 (13), 126 (3), 90 (12), 77
, 75 (7).
1:10-Phenanthroline , 1
89
NMR showed signals at S: 7.5 (2H, ,7.7
(2H,s), 8.15 (2H,dd), and 9.18 (2H,dd). Mass spectral data, m/e (%):
180 (100,M+·), 179 (40), 154 (15), 153 (12), 152 (7), 127 (5), 90
), 63 (7). The l3C NMR spectral data is listed in Table 1.
1 x == s
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The l H NMR included the signals at S: 7.33-7.78 (8H,m),
7.85-8.08 (2H,m), 8.2 (lH,s), and 9.9 (lH,s). Mass sectral data, mle
(%): 228 (100,M+·), 227 (12), 149 (40), 101 (29), 88 (34), 71 (52),
92
57 (88), 55 (80). 13The C NMR spectral data is given in Table 1.
Benz c acridine , 9
The l H NMR included peaks at 6 : 7.38-8.0 (8H,m), 8.33 (2H,dd),
and 8.43 (lH,s). Mass spectral data, mle (%): 229 (100,M+O), 228
(36), 207 (16), 149 (19), 114 (23), 98 (24), 83 (40), 81 (36).
It was synthesized by the series of reactions illustrated in Figure
31. Mass spectral data, mle (%): 170 (66,M+·), 169 (100), 143 (8),
142 (21), 115 (140), 85 (7), 74 (15), 59 (24).
Attempted synthesis of indole , ~
Three different methods for the synthesis of title compound were
attempted, using 10 as the starting material.
Method 1.
Reaction of 10 with Iodine154
The first attempt to synthesise ~, iodine and sodium acetate
were used. 1.5 g of dihydronorharman, ~ was added to 30 mL of ethanol
and 0.75 g of iodine + 1.5 g of sodium acetate were dissolved in the
reaction mixture. The mixture was refluxed for 4 hours, after this the
solvent was evaporated on rotary evaporator. The remaining residue was
dissolved in CHC13 and washed with sodium thiosulphate. The
8 7 69~ 70 ~a ~5
10~ I .# ~40
11 110 ~ 12010 1 4
1~ 3
2
8 X = CH
9 X =N
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Table 1.
Carbon #:
13C NMR spectra of substrates
Compound
94
7 152 8 153
1 122.8
2 150.6 126.7
3 123.4 126.6
4 136.3 128.5
5 126.8 126.9
6 126.9
7 127.2
8 128.3
9 125.6
10 125.7
11 127.6
12 121.4
la 145.6 130.6
4a 129.0 131.9
6a 131.9
7a 131.8
lla 128.8
12a 130 5
Figure 31. Synthesis of Dihydronorharman, l:Q
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compound was extracted with 5% HCI solution. The acidic extract was
neutralized by the addition of ammonia and then extracted with ether.
The extract was dried over anhydrous sodium sulphate and evaporated to
dryness.
The work-up provided 0.95 g of crude extract. Thin layer
chromatography (tIc) of the crude extract showed that it contained only
one compound with an Rf value identical to that of an authentic
sample of 10. The 1H NMR spectrum of the extract was also
identical to that of 10.
Method 2.
Reaction of 10 with 2,3-dichloro-5,6-dicyano-1,4-quinone (DDQ)154
The second attempt to synthesize 1!, DDQ was used. 0.2 g of
dihydronorharman 10 was dissolved in 10 mL of ethanol and 0.2 g of DDQ
was added to the mixture. The mixture was stirred at R.T. and tlc was
checked at regular intervals. After 48 hours of stirring there was no
progress of reaction therefore two drops of cone. HCI were added to the
reaction mixture and it was further stirred for 24 hours.
The work-up provided 0.12 g of crude extract. The tlc and 1H
NMR of this extract were identical to that of starting material.
The reaction was repeated using 0.4 g of DDQ but same results
were obtaind.
Method 3.
Reaction of 10 with Jones' reagent
0.2 g of dihydronorharman 10 was dissolved in acetone. A
97
solution of 0.88 g of chromium trioxide in 4.0 mL of 25% (v/v) aqueous
H2S04 was added dropwise over a period of five minutes and the
reaction was stirred at 5-10 o C for 1 hour. The excess of chromic acid
was destroyed by isopropanol and a saturated solution of sodium acetate.
The mixture was poured into water and extracted with ether. The
ethereal layer was washed with water till neutral, dried over anhydrous
sodium sulphate and the solvent was removed under reduced pressure.
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This work-up gave 0.1 g of crude extract. 1TLC and H NMR of
this sample looked identical to that of a genuine sample of 10.
All the methods for the synthesis of 1! were obviously
unsuccessful and therefore were abandoned.
Triphenylphosphine , 1!
The title compound was purified by recrystallizing the commercially
available impure sample in ethanol. After recrystallization, the pure
compound was obtained in 80% recovery. M.P. 79-80 oC. The l H NMR
showed a peak at S : 7.25 (15H,d). Mass spectral data, m/e (%): 262
(100,M+·), 261 (16), 201 (19), 184 (20), 183 (99), 152 (26), 87
(47), 77 (16).
Dibenzo-1,4-dioxin , ~
1The H NMR spectrum included a single peak at S : 6.75 (8H,s).
Mass spectral data, m/e (%): 184 (100,M+O), 155 (5), 128 (16), 127
(5), 102 (5), 92 (18), 64 (40), 63 (4).
, 14
M.P. 88-89°C. The l H NMR spectrum included signals at S 6.76
p99
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13
(2H,s), 7.1-7.55 (6H,m), and 8.15 (2H,m). Mass spectral data, m/e (%):
206 (97,M+·), 179 (15), 178 (100), 176 (35), 151 (13), 89 (21), 88
(23), 76 (29).
100
1The H NMR spectrum included peaks at '0: 3.0
(4H,s), 6.93-7.40 (6H,m), and 7.95 (2H,m). Mass spectral data, m/e (%):
208 (100,M+·), 207 (45), 193 (8), 179 (55), 178 (53), 165 (26), 152
(10), 89 (24).
Thianaphthene , 16
M.P. 29-32°C. The l H NMR spectrum contained signals at b: 7.3
(4H,m), and 7.75 (2H,m). Mass spectral data, m/e (%): 134
(100,M+·), 133 (5), 108 (4), 90 (10), 89 (10), 69 (4), 67 (5), 63
(5). 13The C NMR spectral data is presented in Table 4.
Alpha-Terthienyl (o(-T) , .!L
M.P. 91-92°C. The l H NMR showed peaks at b: 6.95 (2H,m), 7.1,
and (6H,m). Infrared spectrum contained abrorptions at V : 3060,
max
1440, 860, 795, 685, and 675 cm-l • UV spectrum, \ : 200, 250,
max
and 350 nm. Mass spectral data, m/e (%): 248 (100,M+·), 247 (12),
246 (12), 203 (33), 171 (16), 124 (30), 121 (34), 96 (15).
Thiochroman-4-one , 18
B.P. 154°C. The l H NMR spectrum showed peaks at S : 2.78-3.33
(4H,m), 6.95 (3H,m), and 8.0 (lH,d) Infrared spectrum, ~ : 1682
max
cm-
l (Cyclic ketone). Mass spectral data, m/e (%): 164
o
o
14
101
17
-'
102
(53,M+·), 137 (9), 136 (100), 108 (31), 69 (11). The 13C NMR
spectral data is given in Table 4.
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thiochroman-4-one , 1!
Mass spectral data, m/e (%): 222 (100), 221 (30), 134 (35), 165
(10), 120 (79), 102 (13), 97 (16), 92 (38).
Thioxanthan-9-one , 20
M.P. 210-213°C. The 1H NMR spectrum contained peaks at b: 7.5
"\"'t -1(6H,m), and 8.6 (2H,m). Infrared spectrum, v : 1642 cm
max
(Carbonyl group). Mass spectral data, m/e (io): 212 (100,M+·), 184
(38), 152 (7), 139 (13), 92 (14), 79 (10), 69 (9), 58 (7). The 13C
NMR spectral data is given in Table 4.
thioxanthone , ~
M.P. 93-95°C. The l H NMR spectrum showed signals at b: 2.85
(3H,s), 7.05-7.3 (6H,m), and 8.35 (lH,m). Infrared spectrum, ~ :
max
-1 ( +. )1641 cm (C=O). Mass spectral data, mle (%): 226 100,M ,
225 (46), 197 (42), 165 (13), 152 (10), 113 (10), 94 (13), 78 (10). The
13C NMR spectrum is assigned in Table 6.
thioxanthone , ~
M.P. 122-124°C. The l H NMR spectrum included peaks at b: 2.45
(3H,s), 7.18-7.63 (5H,m), 8.3 (lH,s), and 8.55 (lH,d). Infrared
spectrum, 'V : 1632 cm-1 (C=O). Mass spectral data, mle (70):
max
226 (100,M+·), 225 (12), 197 (32), 165 (9), 113 (9), 94 (16), 78
(9), 69 (19). The 13C NMR is assigned in Table 6.
, 23
--.............:._-----
18 R = H
-
19 R ::;: CH3
20
104
21 1_Methyl
22 2_Methyl
23 3_Methyl
24 4_Methyl
105
M.P. 115-116°C. The 1H NMR spectrum included signals at b :
2.4 (3H,s), 7.08-7.58 (5H,m), and 8.4 (2H,m). IR spectrum, V :
max
1637 cm-1 (C=O). Mass spectral data, m/e (%): 226 (100,M+O),
198 (17), 197 (32), 165 (8), 152 (6), 94 (10), 78 (10), 69 (12). The
13C NMR spectrum is assigned in Table 6.
4-Methylthioxanthone , 24
106
1The H NMR spectrum showed peaks at b: 2.45
(3H,s), 7.15-7.6 (5H,m), 8.45 (2H,m). Infrared spectrum,~ : 1632
max
-1 +
cm (C=O). Mass spectral data, m/e (%): 226 (100,M e), 225
(13), 197 (38), 165 (71), 152 (8), 98 (8), 94 (17), 77 (11). The
13C NMR spectrum is assigned in Table 6.
Canadine , !?
Mass spectral data,m/e (%): 339 (49,M+-), 338 (28), 308 (9),
278 (3), 174 (23), 165 (24), 164 (100), 149 (83).
,~
Mass spectral data, m/e (%): 355 (58,M+·), 354 (46), 324 (12),
190 (30), 165 (24), 164 (100), 149 (88), 121 (24).
,!:l.
Mass spectral data, m/e (%): 369 (26,M+·), 368 (9), 354 (8),
179 (14), 178 (100), 163 (23), 135 (10), 91 (9).
1The H NMR spectrum contained signals at 6: 1.25
(3H,t,J=6Hz), 2.6 (2H,q,J=6Hz), and 7.1 (5H,s). Mass spectral data, m/e
(%): 106 (37,M+O), 105 (8), 92 (8), 91 (100), 77 (9), 65 (8), 51
25
26 R ~ H
27 R ~ CH3
107
(10) •
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1The H NMR spectrum included signals at b: 1.25
(3H,t,J=6Hz), 2.35 (3H,s), 2.6 (2H,q,J=6Hz), and 7.1 (4H,s). Mass
spectral data, (%): 120 (32,M+·), 119 (4), 106 (15), 105 (100),
103 (5), 91 (9), 79 (8), 77 (9).
p-Diethylbenzene , 28c
B.P. 184°C. The l H NMR showed the signals at S: 1.2
(6H,t,J=6Hz), 2.58 (4H,q,J=6Hz), and 7.05 (4H,s). Mass spectral data,
m/e (%): 134 (45,M+·), 120 (10), 109 (100), 117 (10), 105 (74), 103
(8), 91 (23), 77 (11).
p-Methoxyethylbenzene , 28d
1The H NMR showed the peaks at 6 : 1.2 (3H,t,J=6Hz), 2.53
(2H,q,J=7Hz), 3.65 (3H,s), and 6.73, 7.0 (4H,AB quartet,J=8Hz). Mass
spectral data, m/e (%): 136 (29,M+·), 124 (4), 122 (9), 109 (15),
105 (7), 91 (7), 77 (9).
, 28e
The l H NMR showed the signals at S : 1.18 (3H,t,J=7Hz), 2.3
(2H,q,J=7Hz), 6.78-7.28 (4H,m). Mass spectral data, m/e (%): 124
(28 ), 120 (5), 110 (7), 109 (100), 105 (13), 103 (6), 83 (7), 51
(4) •
..a-. ~ ' 28£
The l H NMR included the signals at S : 1.18 (3H,t,J=7Hz),
2.58 (2H,q,J=7Hz), and 7.08 (4H,AB ,J=8Hz). Mass spectral data,
mle (%): 142 (12), 140 (38), 127 (32), 125 (100), 103 (10), 89 (9), 77
(10).
2.2 g (1.7 mL; 0.012 mole) of p-bromoethylbenzene and 1.18 g
(0.0132 mole) of cuprous cyanide were heated in refluxing N,N-dimethyl
formamide (40 mL), under nitrogen for four hours. The cooled reaction
mixture was poured into the solution of ferric chloride hydrate (6.0 g)
in concentrated hydrochloric acid (2.0 mL) and water (10 mL), heated for
about 20 minutes at 50-60 GC, brought to room temperature and extracted
with ether (4 x 50 mL). The extracts were combined, washed with 5%
sodium hydroxide solution (35 mL), water (4 x 50 mL), and dried over
anhydrous sodium sulphate. The solvent was removed over rotatry
evaporator.
This work-up provided 1.7 g of crude extract. TLC of the extract
showed that it contained one major component with an Rf lower than
that of starting material. The extract was chromatographed on a column
of silica gel (170 g) by stepwise elution from benzene to ether (steps
of 5% ether). 1.3 g of pure compound was isolated giving one spot on
tlc. Its l H NMR spectrum included peaks at 6: 1.25 (3H,t,J=8Hz),
2.7 (2H,q,J=8Hz), and 7.2, 7.5 ,AB ,J=9Hz). Infrared
spectrum, -V : 2227 cm-1 (CsN). Mass spectral data, mle (io):
max
131 (36,M+·), 130 (6), 117 (10), 116 (100), 103 (8), 89 (11), 85
(14), 83 (21).
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, 28h
1The H NMR spectrum of the title compound contained signals at 6
1.08 (3R, J=8Hz), 2.45 (2H,q,J=8Hz), 3.33 (2H,br,s), and 6.40, 6.78
(4H,AB quartet,J=8Hz). Mass spectral data, m/e (%): 121 (38,M+·),
120 (6), 107 (8), 106 (100), 79 (4), 77 (9), 53 (5).
156 28i
, --
3.27 g (0.027 mL)p-ethylaniline, 2.7 g (2.5 mL; 0.0265 mole)
acetic anhydride, and a pinch of zinc dust were placed in 125 mL boiling
flask fitted with a condenser. The reaction was boiled gently for one
hour, cooled to room temperature and extracted with ether (5 x 50 mL).
The extracts were combined, washed with water (3 x 50 mL) and dried over
anhydrous sodium sulphate. The solvent was removed on a rotary
evaporator and the resulting brown solid on recrystallization from a
mixed solvent system of ethanol/water afforded white crystals giving one
spot on tic, (yield 1.28 g; 30%); m.p. 90-92°C. Its 1H NMR included
signals at 6 : 1.18 (3H, J=8Hz), 2.08 (3H,s), 2.55 (2H,q,J=8Hz), and
7.05, 7.33 (4H,AB quartet,J=8Hz). Mass spectral data, m/e (%): 163
(29,M+·), 121 (35), 120 (4), 107 (8), 106 (100), 91 (3), 77 (7), 65
(3) •
110
, 28j
M.P. 42-45°C. The NMR Spectrum of the title compound showed
signals at S: 1.15 (3H,t,J=7Hz), 2.55 ( q,J=7Hz), 5.5 (lH,s), and 6.65,
7.0 quartet,J=7Hz). Mass spectral data,
(38,M+·), 108 (5), 107 (100), 77 (8).
29
NMR spectrum included peaks at S: 0.9
R
28
a· R - HJ
bt R - CH3J
c· R - C2 H5J
d· R - OCH3J
e· R .....,. F)
f· R == ClJ
gj R := CN
h· R =:; NH2J
. R NHCOCH3I · -J
. R OHJj ~
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(3H,t,J=6Hz), 1.63 (2H,m), 2.56 (2H,t,J=6Hz), and 7.12 (5H,s). Mass
spectral data, mle (%): 120 (21,M+·), 105 (6), 92 (12), 91 (100), 78
(6), 77 (5), 65 (11), 51 (6).
p-Methylacetophenone, 35b (10 g; 0.075 mole) and sodium
boro-hydride (11.3 g; 0.0297 mole) were dissolved in 40 mL of isopropyl
alcohol and the mixture was stirred for 40 hours at room temperature.
After this the solvent was evaporated at reduced pressure and 300 mL
water was added. The product was extracted with ether (5 x 60 mL). The
ethereal layer was washed with water (3 x 300 mL) in order to remove
inorganic impurities, and dried over anhydrous sodium sulphate. The
solvent was removed on rotary evaporator and 7.8 g (78% yield) product
was obtained. TLC indicated that this consisted of a single product.
1The H NMR spectrum included signals at G: 1.3 (3H,d,J=6Hz), 2.25
(3H,s), 3.25 (lH,br,s), 4.65 (lH,q,J=6Hz), and 7.0 (4H,s). Mass
spectral data, m/e (%): 136 (24,M+·), 121 (100), 118 (35), 115 (16),
93 (93), 92 (24), 91 (94), 77 (50).
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Attempted synthesis of
A solution of 1.36 g (0.01 mole) of p-Methyl-l-phenylethanol, 30
in 2 mL CFCl3 was s added to a solution of 1.16 g (0.01 mole)
diethylaminosulfur trifluoride (DAST) in 5 mL CFCl3 cooled to -78°C.
The reaction mixture was warmed to room temperature, mixed with cold
water and extracted with ether (4 x 50
combined, washed with water (4 x 50
The ether extracts were
and dried over MgS04 • The
29
C( H3
H-C-OH
30
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solvent was evaporated on rotary evaporator.
This work-up provided 0.8 g of crude extract. Thin layer
chromatogaphy of the crude extract showed that it contained only one
component with an Rf identical to that of starting material, 30 •
1H NMR was also identical to that of a genuine sample of 30.
Attempted synthesis of e-Methyl-1,1-difluoroethylbenzene 157, 32
A 4.0 g (4 mL; 0.03 mole) sample of p-Methy1 acetophenone, 35b was
slowly added to a solution of 4.8 g (3.64 mL; 0.03 mole) of DAST in 15
mL of glyme at 25°C. The reaction was stirred at 85°C, brought to room
temperature and then mixed with 50 mL water. The organic layer was
extracted with ether (4 x 50mL), washed with water, dried (MgS04),
and solvent was evaporated.
This work-up provided 3.0 g of crude product. TLC of the crude
extract indicated that it contained only one component with an Rf
114
value identical to that of starting material. The NMR spectrum
was also identical to that of starting material. It included signals at b
2.35 (38,s), 2.5 (38,s), and 7.13, 7.75 (48,AB quartet,J=8Hz).
The reaction was repeated using freshly dried and distilled
solvent. The solvent, glyme was dried by treating it with LiA184
under nitrogen The same result was obtained. This method
for synthesis of 32 was obviously unsuccessful and therefore was
abandoned.
Attempted synthesis of , 35
For the synthesis of title compound a series of reactions
illustrated in Figure 32, was proposed.
For the synthesis of 34 , trifluoroacetophenone, 36 was treated
with NaBH4 under same conditions and same work-up procedure was
followed as described for the synthesis of 30, but the reaction did
not occur. Due to the failure of this reaction, proposed scheme for the
synthesis of 35 can not proceed further and therefore was abandoned.
Acetophenone , 33a
115
1Its H NMR spectrum showed peaks at b : 2.62
(3H,s), 7.45 (3H,m), and 8.0 (2H,m). Mass spectral data, m/e (%): 120
(18,M+·), 105 (100), 106 (9), 102 (32), 78 (11), 77 (84), 51 (34),
50 (17).
p-Ethylacetophenone , 33c
B.P. 125°C. The l H NMR spectrum of the title compound
contained peaks at 6: 1.26 (3H,t,J=7Hz), 2.43 (3H,s), 6.6 (2H,q,J=7Hz),
and 7.15, 7.76 (4H,AB quartet,J=8Hz). Mass spectral data, m/e (%): 148
(21,M+·), 134 (10), 133 (100), 105 (28), 103 (8), 77 (11), 51 (5).
0< ,p( ,0< -Trifluoroacetophenone , ~
B.P. 165-166°C. The l H NMR spectrum showed signals at 6: 7.6
(3H,m) and 8.05 (2H,d,J=6Hz). Mass spectral data, m/e (%): 174
(8,M+·), 106 (7), 105 (100), 78 (6), 77 (9), 74 (5), 51 (35), 50
(14) •
31 32
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R
33
-
a· R::= H)
bj R = CH3
R == C2H3
Figure 32. Proposed route for the synthesis of
l,l,l-trifluoroethylbenzene, 35
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NaBH4
>
34
SOCl2
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lLi Al H4
yF3
H-C-H
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PART TWO
Microbial Incubations
118
Section A
Biotransformation of Polycylic Aromatic Compounds by Fungi
119
1. Incubations with Cunninghame1la elegans ATCC 26269 10,57
a Preparation and Growth Conditions of Fungal Cultures
The fungi was grown in medium composed of Sabouraud dextrose broth
(Difco), 30 g per Litre of distilled water. The fungi was grown in 1
Litre Erlenmeyer flasks, each containing 150 mLof the medium. The
flasks were fitted with sponge plugs, sterilized at 15 pounds pressure,
120°C, for 20 minutes, allowed to cool and inoculated (using an
inoculation loop) from growing slopes of Cunninghame11a e1egans The
flasks were then placed on a rotary shaker operating at 250 rpm at 30°C.
b General Design of Experiments
The fungal cultures were grown under the conditions described above
for 72 hours. After 72 hours the medium was removed by filtration, and
the mycelial pellets were washed 3 times with sterile water, macerated
in a Waring blender and resuspended in sterile Sabouraud dextrose broth
(150 mL/flask). The substrate dissolved in 95% ethanol (100 mg in 2 mL)
was added to each flask. Incubation was then continued under the same
conditions as described above for 96 hours. After the incubation period
has passed, the mycelium was filtered, and the culture filtrate was
extracted three times with acetate or dich1oromethane. The
mycelial pellets macerated in a Warying blender with ethyl acetate or
dichloromethane and filtered. This process was also repeated three
times. The extracts were dried over anhydrous sodium sulphate, and the
solvent was removed under reduced pressure. Each of the residues from
120
the medium and mycelia were examined for metabolic products by thin
layer chromatography and subjected to silica gel column chromatography
as desired.
A series of control experiments was also performed in some cases as
described below.
(I) Incubations with autoclaved fungi were carried out as
154follows. The washed mycelial pellets were resuspended in medium
and then the flasks were autoclaved under the same conditions as
described above. After cooling, the substrate was added and subsequent
operations were performed as before.
121
(II) 65Incubations with attempted induction were tried as follows.
The fungus was grown for 48 hours exactly in the same way as in la,
followed by the addition of inducer substrate (80 ~m) and further
incubation for 24 hours (induction period). Following an initial three
day period of growth and induction~ incubation with the substrate was
performed under identical conditions as mentioned in lb and subsequent
work-up procedure was adopted.
(III) Incubations using cycloheximide as a protein synthesis inhibitor
f d f 11 158~159were per orme as 0 ows. After the standard three day
growth period of C. , cyclohexamide (100 ~g/ml), and
substrate was added to the resuspended fungus in medium and the
incubation was continued according to the conditions previous
described. When the incubation time had elapsed, the mycelia were again
separated from the medium and both were worked-up separately, as
described before.
Incubation # 1
Incubation of this substrate (2.4 g), gave extracts from medium
(1.15 g) and mycelium (1.03 g). The former appeared to be a complex
mixture (from tlc). The column chromatography of this mixture yielded
only starting material in pure form (0.2 g, 8.3% recovery). No other
compound can be separated in pure form to be characterized. The latter
extract was analysed by tlc in benzene/ether (3:1, v/v) revealed the
presence of dibenzothiophene ! , and two oxidation products (Rf
0.78 and 0.16). Each of the metabolites absorbed U.V. light and showed
no reaction with Gibb's reagent. This solid residue was chromatographed
on deactivated silica gel (20% water) using benzene-ether and afforded
the following components in order of decreasing Rf values.
Dibenzothiophene,! (0.4 g, 16.7% recovery), identical with an
authentic sample; and dibenzothiophene-9,9-dioxide, ~ (79 mg, 2.8%),
m.p. 232-235°C (lit. 160 m.p. 236°C); 1H NMR 6 : 7.53 (4H,m), and
7.75 (4H,m); IR ~ : 1165 and 1288 cm-1 ; UV ~ : 277,
max max
122
288, 316 nm; MS mls (%): 216 (100,M+·), 187 ), 171 (19), 168
(50), 160 (40), 149 (38), 136 (42); Anal. calcd. for
C12H802S: C 66.66, H 3.70, S 14.81%; found: C 66.45, H 3.88,
13S 14.57%; The C NMR spectrum is assigned in Table 3. The second
isolated product was identified as dibenzothiophene-9-oxide, 38 (12 mg,
0.5%), m.p. 189-190oC (lit. 160 m.p. 188°C); 1H NMR b: 7.5
123
5
11
o
37
s
cf~
38
(4H,m) and 7.85 (4H,m); IR ~ : 1165, 1216, 1270 cm -1 MS m/e
max
(%): 200 (6,M+·), 185 (14), 184 (100), 155 ), 139 (20), 92 (11),
69 (10).
Incubation of 1 with C. elegans was repeated. The fungus was
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grown standard procedure as described in section la, at the end of
growth period the fungal mycelia were filtered off, washed and
resuspended, not in medium but in sterile water and incubation was
carried out by normal procedure. Incubation of 1.2 g of substrate
provided extracts from medium (0.45 g), and mycelium (0.5 g). Thin
layer chromatography of crude extracts showed no metabolic product in
either of them. Starting material and some highly non-polar endogenous
fungal material was detected.
Two control incubations were also performed with this compound.
(i) In the first control experiment, 200 mg of 1 was incubated with
an autoclaved culture of C. elegans. This incubation provided
extracts which showed only one spot on the tlc with Rf identical to
that of an authentic sample of 1. No non-enzymic transformation had
taken place.
(ii) In the second control experiment dibenzothiophene was incubated in
the presence of cycloheximide. TLC analysis of mycelial extract
indicated the formation of which were characterized as
corresponding sulphone, 37 and sulphoxide, 38 •
Incubation # 2
, 2
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Incubation of 2 (1.6 g) provided extracts from mycelium (330 mg)
and medium (70 mg). TLC analysis of both the residues in benzene/ether
(3:1, v/v) indicated the presence of starting material (Rf 0.78) and
one transformation product which absorbed U.V. light and gave a blue
colour with Gibb's reagent. The former extract was chromatographed on
respects to ·39 , obtained earlier.
The latter extract was subjected to preparative layer
chromatography. This provided 5 mg, 0.3% of compound identical in all
13The C NMR spectrum is assigned in Table 3.
A control incubation with this substrate,! was also carried out.
ether), the following components were identified: dibenzopyrrole, 2
silica gel by stepwise elution from benzene to ether (increments of 5%
(150 mg, 9.3) and 2-hydroxydibenzopyrrole, ~ (12 mg, 0.7%), m.p.
253-254°C (lit161 m.p.260-261°C); NMR (acetone-d~ 6:
6.83-7.53 (5H,m), 7.83-8.0 (lH,d,J7,8=7.5,C-8H), and 7.93
(lH,s,C-1H); IR ~ : 2853, 2924, 2959, 3399 cm-1 ; MS m/e (%):
max
183 (100,M+·), 182 (14), 154 (19), 127 (11), 91 (21), 77 (14), 63
(7), 57 (7).
The compound (200 mg) was incubated with the fungus in the presence of
cycloheximide (protein synthesis inhibitor). TLC analysis (spray with
Gibb's and mass data of medium extract indicated the
the formation of 2-hydroxydibenzopyrrole, 39.
Incubation # 3
Fluorene , 3 •
Incubation of (1.0 g) of title compound gave 0.75 g of extract.
Both the medium and mycelium appeared to be complex mixtures. Column
chromatography of both mixtures on silica gel (75 g) using benzene to
ether (steps of 10% ether) gradient elution led to the recovery of only
starting material (0.4 g, 40%). The recovered substrate was identified
by comparison of spectral and physical data of a genuine sample of 3
Incubation # 4
9-Fluorenone , 4
Incubation of 4 (0.5 g) gave extracts from medium (50 mg) and
mycelium (310 mg). The latter extract contained natural fungal
products, plus 4 as the only readily detectable material. The former
extract was chromatographed on silica gel using a benzene to ether
solvent gradient elution (steps of 5% ether). The following components
were identified: 9-fluorenone, i (20 mg), identical to starting
material and 9-hydroxy fluorene, 40 (7 mg, 1.4%), m.p. 215-218°C
162 1 ~(lit. 153-154°C); H NMR 0 :5.6 (lH,s), 7.35 (4H,m), and 7.68
" -1 . +.)
,m); IR V : 3189 em ; MS m/e (%): 182 (77,M ,181
max
(100), 166 (51), 164 (12), 153 (21), 151 (12). The 13C NMR
is assigned in Table 3.
Incubation # 5
Acridine , 5
Incubation of 5 (2.4 g) gave crude extract (2.1 g). Both medium
and mycelial extracts appeared to be complex mixtures (from tlc).
Chromotography of both extracts on silic gel column using benzene to
acetone gradient elution (10% increments of acetone) provided starting
126
39
OH
40
-
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Table 2. 13C NMR spectra of substrates
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Carbon :#
*1 *2
Compound
3 163 4 5 164,165
1 124.7 120.0 119.8 120.3 130.5
2 122.0 125.4 126.7 134.6 125.7
3 123.0 118.4 126.7 129.0 128.5
4 127.1 110.9 125.0 124.2 129.7
1a 135.1 122.4 141.7 144.4 126.7
4a 138.7 139.7 143.2 134.1 149.3
9 36.9 193.7 136.1
* Solvent DMSO-d6
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Table 3. Assignment of 13C NMR spectra of Dibenzothiophene-9,9-dioxide, 1I ,
2-Hydroxydibenzopyrrole, ~ , and 9-Hydroxyfluorene, 40
*1 122.0 110.7 120.1
2 134.6 150.3 127.9
*3 122.7 104.8 129.2
4 131.0 114.9 125.3
5 111.1
6 117.6
7 125.0
8 119.9
9 75.4
1a 137.0 123.0 140.2
4a 137.0 133.7 145.8
5a 140.3
8a 122.2
Carbon I
37 a
Compound
39 a 40 b
* Chemical shifts marked with asterisks may be interchanged.
a All shifts in ppm relative to solvent DMSO-d6 at 39.5 ppm.
b All shifts in ppm relative to solvent CDC13 at 77.2 ppm.
.6 g) provided 1.4 g of extract. TLC of both
material (0.8 g) plus a metabolic product (180 mg) which appeared to be
a hydroxylation product (tlc gave a blue colour with Gibb's reagent).
This product still appeared to be contaminated with less polar natural
fungal products. The product was therefore rechromatographed by
preparative tlc. This provided a metabolite (40 mg) in an impure form.
The mass spectrum of this metabolite showed a molecular ion at m/e 195
corresponding to the addition of one oxygen atom to the substrate.
Further characterization was not possible due to the limited quantity
and the impure state of the material.
A control experiment with this compound was also performed. The
substrate 5 (1.0 g) was incubated with the culture of C. e1egans
which was induced with the same compound. The incubation provided
extracts from medium (0.66 g) and mycelium (.036 g). The former
contained nonpolar endogenous fungal material in addition to starting
material as the only readily detectable compound (t1c) and was not
examined further. The latter extract was chromatographed on silica gel
(gradient elution from hexane through benzene to ether, steps of 10%)
and afforded 5 (0.15 g) and traces of an oxidised metabolite (tlc and
mass spectrum) which could not be isolated in sufficient quantity for
complete characterization.
Incubation # 6
Phenanthridine , !
of 6
the medium and mycelium extracts showed that they contained only
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unmetabolized substrate.
Incubation # 7
1:10 , I
Incubation of 7 (1.0 g) gave 0.85 g of extract. Both the
mycelium and medium extracts gave a spot with Rf identical to that
of an authentic sample of I and several spots with larger Rf
values. There was no indication of more polar oxidation products.
Incubation # 8
Benz[a]anthracene , 8
Incubation of 8 (45 mg) provided 34 mg of crude extract. TLC
showed the major component to be the starting material. Further
analysis by mass spectroscopy indicated only the starting substrate.
Incubation # 9
Benz c acridine , !
Incubation of 9 (190 mg) gave 150 mg of crude extract. Thin
layer chromatography showed the presence of only starting material. The
mass spectrum of the crude extract was characteristic of 9.
Incubation # 10
,g
Incubation of 12 (0.5 g) gave extracts from medium (0.12 g) and
mycelium (0.3 g). The latter contained natural material and 12
as the readily detectable (tlc) substance and was not examined
further. TLC of medium extract revealed the presence of mainly one
component with a value lower than the starting substrate.
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Recrystallization of the medium extract from ethanol provided 90 mg ,
(18% yield) of triphenylphosphine oxide, 41, identical in all respects
with commercial sample of 41, m.p. 153-154°C (lit. 166 m.p.
156-157°C); l H NMR b : 7.52 (9H,m), 7.75 (6H,m); IR ~ : 1120,
max
-1 +.1178, 1436, 1672, 2929, 2962 cm ; MS (%): 277 (38,M ), 201
(10), 154 (23), 125 (15), 111 (21), 83 (38), 69 (66), 57 (100).
A control incubation experiment was also carried out with this
substrate. The starting material, 12 (200 mg) was incubated with an
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autoclaved culture of C. Work-up of this incubation
provided, triphenylphosphine oxide, 41 , identified by comparison with a
commercial sample.
Incubation # 11
Dibenzo-l,4-dioxin , l!
Incubation of 13 (200 mg) provided 130 mg of crude extract. TLC
showed the major component to be the starting substrate. Further
analysis by mass spectroscopy showed that only starting material was
Incubation # 12
,14
Incubation of 14 (0.5 g) gave 0.87 g of crude extracts. TLC of
these extracts showed that they contained unchanged starting
material. The mass spectrum of the recrystallized extract showed the
fragmentation characteristic of the starting substrate, 14 •
Incubation # 13
crude extract from this culture gave a spot with similar to that
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of a genuine sample of .~ and several spots with greater Rf
values. There was no sign of more polar oxidation product and was
therefore, not examined any further.
Incubation :IF 14
Thianaphthene , .!!
Incubation of 16 (1.4 g) gave 1.27 g of crude extract. Thin
layer chromatography of this extract revealed the presence of only
unmetabolized substrate. The recrystallization of crude extract yielded
(0.9 g, 64% recovery) of 16 identical to the starting material.
Incubation # 15
,Q
Incubation of 17 (0.8 g) 0.94 g of crude extract. The
extract appeared (from tlc) to be a complex mixture. The extract was
chromatographed on silica gel (gradient elution from hexane through
benzene to ether) and gave Q, (0.55 g, 69% recovery), identified by
comparison with an authentic sample. A non-polar component was also
obtained. Mass spectral analysis of this species determined that it was
not an oxidation t.
Incubation :[I: 16
Thiochroman-4-one , 18
Incubation of 18 (0.4 g) gave extracts from medium (0.24 g) and
mycelium (0.34 g). TLC analysis of both the extracts indicated the
presence of more polar oxidation product apart from the starting
substrate. Both the extracts were pooled and chromatographed on a
silica gel column using benzene-ether-ethyl acetate gradient (increments
of 10% polar solvent) as eluting solvents and afforded 18 (0.15 g, 38%
recovery) and thiochroman-1-oxide, 42 (0.63 mg, 16% yield). 1H NMR S
: 2.8 (2H,m), 3.35 (2H,m), 7.68 (3H,m), and 8.08 (lH,m); IR ~ :
max
-1 +1030, 1052, and 1689 cm ; MS m/e (%): 180 (7,M .), 164 (44),
162 (10), 152 (72), 136 (100), 108 (33), 96 (18), 76 (14); The 13C
NMR spectrum is assigned in Table 5.
Incubation :IF 17
,!2.
Incubation of 19 (0.21 g) gave 0.12 g of extract. Analysis of
crude extract by tlc revealed the presence of only starting substrate,
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which was also supported
Incubation :IF 18
Thioxanthan-9-one , !Q.
mass spectral anlysis.
Incubation of 20 (1.0 g) gave an extract (1.29 g). TLC of the crude
extract in benzene/ether (3:1, v/v) revealed the presence of starting
material 20 and two oxidation products (Rf 0.36 and 0.76). The
extract was chromatographed on silica gel by stepwise elution from
benzene to ether (increments of 10% ether) and afforded 20 (0.524 g,
53% recovery); thioxanthone-l0,10-dioxide, 43 (20 mg, 2% ),
m.p.183-186°C (lit. 167 m.p. 185-187°C); 1H NMR S : 7.8 (4H,m)
and 8.4 (4H,m); IR ~ : 1054, 1144, 1168, 1294, and 1680; MS
max
(%): 244 (13 ), 212 (8), 197 ( ,196 (100), 180 (10), 168 (16),
151 (10), 136 (39); The 13C NMR is assigned in Table 5.
The second component isolated was not pure so it was separated
preparative tIc (benzene/ether, 3:1). This provided
thioxanthone-l0-oxide, 44 (5 mg, 0.5% yield), m.p. 199-201°C
. 167 . . 1(11t. m.p. 200-204°C); H NMR S: 7.7 (4H,m) and 8.2 (4H,m);
" -1IR V : 1038, 1264, and 1667 cm ; MS m/e (%): 228 (1.4
max
,M+·), 212 (100), 184 (39), 139 (14), 104 (15), 83 (15).
Incubation # 19
l-Methylthioxanthone , ~
Incubation of 21 (0.4 g) provided an extract (0.35 g) which was
chromatographed on silica gel column using benzene to ether solvent
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gradient (s of 10% ether) to give 1-Methylthioxanthone, ~ (0.09 g,
23% recovery) identical with the starting material;
1-Methylthioxanthone-l0,10-oxide, 45 (10 mg, 2.5% yield), m.p.
200-202°C (lit. 168 m.p. 201-203°C); NMR S: 2.79 (3H,s),
7.43-7.78 (4H,m), and 7.93-8.18 (3H,m); IR V : 1125, 1151, 1308,
max
and 1672 cm-1 ; MS m/e (%): 258 (99,M+·), 226 (77), 210 (68), 209
(19), 197 (27), 181 (20), 165 (100), 149 (19); 13C NMR spectrum is
assigned in Table 7; and l-Hydroxymethylthioxanthone-l0-oxide, 49 , (28
mg, 7% after recrystallization from hexane), m.p. 166-168°C;
1H NMR S: 3.4 (lH,br,s,exchanges D20,OH), 4.8 (2H,q,J=12Hz),
7.5-7.85 (4H,m), and 7.9-8.23 (3H,m); IR V : 1028, 1052, 1660, and
max
41
o
o
s
II
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Table 4. 13C NMR of substrates
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Carbon :fI:
16 169
Compound
18 170 20 171
1 129.9
*2 122.6 26.6 126.0
3 126.3 39.5 132.3
-Ir4 124.3 193.8 126.3
5 123.8 129.1
6 123.9 124.9
7 124.4 133.1
8 127.5
9 180.0
1a 140. 142.1 129.3
*3a 139.9
4a 130.9 137.3
* Chemical shifts marked with asterisks may be interchanged.
Table 5. 13Assignment of C NMR spectra of Thiochromanone-1-oxide, 42
and Thioxanthone-10,10-dioxide, 43
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Carbon #
42 169
Compound
43 a
1 129.2
2 46.8 134.7
3 30.4 133.2
4 192.0 123.6
*5 129.1
6 132.2
7 134.6
*8 128.5
9 176.7
1a 145.7 130.6
4a 129.7 140.4
* Chemical shifts marked with asterisks may be interchanged.
a All shifts in ppm relative to CDCl3 at 77.0 ppm.
3377 -1cm MS m/e (%): 258 (7,M+·), 141 (30), 224 (99), 212
140
(71), 196 (100), 184 (58), 152 (76). An accurate mass/atomic composition
spectral analysis was also carried out. The determined mass (258.0363)
was in close agreement with the calculated mass of 258.0350 for
C14Hl003S with a deviation of 1.3 mmu. The 13C NMR
spectrum of the compound was too complex (perhaps due to the
decomposition of compound in CDCl3) to aid in structure
determination, however, the peak for methyl carbon was absent and a peak
at 64.5 ppm corresponding to benzylic carbon with hydroxyl group was
observed. Rf values: Chloroform/Methanol (95:05, v/v), 0.76;
Benzene/ether (75:25, v/v), 0.68
Incubation # 20
2-Methylthioxanthone , ~
Incubation of 22 (0.5 g) gave extract (0.61 g) which was
chromatographed on silica gel column by stepwise elution from benzene to
ether (increments of 10% ether) to give 22, (0.17, 34%) identical in
all respects with starting material and
2-Methylthioxanthone-l0,10-dioxide, 46 (25 mg after recrystallization
from Chloroform-Hexane, 5% yield), m.p. 203-205°C (lit. 168 m.p.
NMR S : 2.38 (3H,s), 7.45-7.93 (4H,m), 7.98 (lH,s),
and 8.05-8.38 (2H,m); IR)) : 1125, 1146, 1160, 1291, 1672
max
-1
cm ; MS (%): 258 (34 ), 226 (9), 210 (100), 209 (12),
181 (18), 165 (29), 150 (11), 136 (25); The 13C NMR spectrum is
assigned in Table 7.
Incubation # 21
Incubation of 23 (0.5 g) gave an extract (0.66 g) which was
applied to the top of a column of silica gel in benzene. The column was
eluted with ether-benzene (increments of 10% ether) to give in order of
elution, ~ (0.36 g, 72% recovery), identical with starting substrate;
3-Methylthioxanthone-l0,10-dioxide, 47 (22 mg, 4.4%), m.p. 205-206°C
(lit. 168 m.p. 206-207°C); 1H NMR S: 2.48 (3H,s), 7.39-7.80
(2H,m), 7.85 (lH,s), and 7.98-8.38 (4H,m); IR V : 1155, 1299,
max
-1 +1318, and 1674 cm ; MS m/e (%): 258 (39,M .), 210 (100), 181
(17), 165 (34), 150 (19), 136 (19); 13C NMR spectrum is assigned in
Table 7; and 220 mg of a substance which appeared to be an oxidation
product (tlc, rns, and nmr). However it was not pure, so the column
chromatography was repeated using the same solvent system as above.
This provided (30 mg, 6%, m.p. 159-160 0 C) of a product tentatively
assigned the structure, 3-Hydroxymethylthioxanthone, 50 ; 1H NMR b:
4.75 (2H,s), 7.48 (5H,m), and 8.5 (2H,m); IR ~ : 1632, 2917, and
max
-1 +3401 cm ; MS m/e (%): 242 (100,M .), 241 (19), 226 (11), 211
(13), 197 (14), 183 (11). This incubation product was still impure
giving one other spot on tlc with Rf higher than that of 50 or
starting material 23. The presence of this impuri meant that the
elemental analysis of the product was not helpful and m.p. was not
reliable. However, elemental analysis is listed here. Anal. calculated
for C14 H10 0 S: C 69.42, H 4.13, S 13.22%; Found: C 67.37, H
141
6.10, S 13.44
Incubation # 22
4-Methylthioxanthone , ~
Incubation of 24 (0.4 g) provided an extract (0.49 g) which
appeared (tIc) to contain one major component, more polar than starting
material. In order to isolate this species, the crude extract was
chromatographed on silica gel using a benzene to ether solvent gradient
(steps of 10% ether). The chromatography afforded in order of
decreasing Rf , 24 (50 mg, 12.5% recovery) identical in all
respects with starting material, and 4-Methylthioxanthone-10,10-dioxide,
16848 (40 mg, 10% yield), m.p. 178-180 oC (lit. m.p. 181-182°C);
1H NMR 6 : 2.83 (3H,s), 7.5 (2H,d), 7.6-7.88 (2H,m), and 7.95-8.33
_\ -1(3H,m); IR ~ : 1117, 1136, 1153, 1294, 1308, and 1672 cm ; MS
max
m/e (%): 258 (100,M+·), 241 (3), 226 (16), 210 (99), 184 (9), 181
(21), 165 (59); 13C NMR is assigned in Table 7.
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o~ 1_MethYl
46 2_Methyl
47 3_Methyl
48 4_Methyl
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Table 6.
Carbon :f/:
13Assignment of C NMR spectra of Methyl substituted
Thioxanthones. a
Compound
145
21 22 23 24
* 127.71 144.0 129.8 129.9
*2 129.8 136.3 126.3 126.4
.,'f
3 131.2 133.6 144.4 133.4
4 124.4 126.0 127.9 134.0
*5 126.2 126.0 126.0 125.6
*6 131.8 132.0 132.1 132.2
.,'f
7 125.3 126.0 125.8 126.4
*8 130.4 129.6 129.9 129.7
9 182.6 180.0 179.8 180.4
la 129.5 129.1 127.2 129.0
4a 138.7b 134.2 137.4 Not Seen
5a 138.7b 137.5 137.4 136.8
8a 124.6 129.1 129.5 129.0
Methyl 24.9 21.2 21.7 19.4
* Chemical shifts marked with asterisks may be interchanged.
a All shifts in ppm relative to CDCl3 at 77.2 ppm.
b Very weak.
Table 7. Assignment of 13C NMR spectra of Methyl substituted
Thioxanthone-l0,10-dioxdiesa
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Carbon :fI:
45 46
Compound
47 48
129.4* ",:1 142.9 129.1 127.3
2 137.1 144.3 134.5 138.0
* **3 133.0 135.3 146.5 132.9
123.6"':** ",:*4 122.0 123.6 137.1
123.5*** **5 123.0 123.5 123.4
*6 133.3 133.1 133.2 132.2
* **7 133.5 134.6 134.0 134.8
* ",:8 129.0 129.1 129.3 128.5
9 181.9 178.6 178.0 178.1
128.7b **,,':-kla 130.5 128.1 129.3
142.0b **-If4a 138.2 140.9 142.2
141.1 *,,':,,'f5a 139. 140.8 138.4
126.4b ****8a 130.8 130.6 130.8
Methyl 22.8 21.7 22.0 19.8
* Chemical shifts marked with asterisks may be interchanged.
a All shifts in ppm relative to CDCl3 at 77.0 ppm.
b Very weak.
Incubations with ATCC 11145 172
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Preparations and Growth Conditions of Fungal Cultures
The growth medium for this fungus composed of 50 g of glucose, 20 g
of peptone, and 3 mL of corn steep per litre of distilled water.
The fungus was grown utilizing l-L Erlenmeyer flasks, each containing
150 mL of the medium and fitted with sponge plugs. Prior to inoculation
with fungi, the medium was sterilized and cooled to room temperature.
The flasks were then incubated and grown out at room temperature for 96
hours on a rotary shaker at 180 rpm.
b. General Design of Experiments
Following an initial four day growth period under the conditions
described above the mycelia were then separated from the medium by
filtration, washed with distilled water, cru~hed in a Waring blender
with distilled water and aliquots were resuspended in distilled water
(150 mL in each flask). A solution of substrate (100 mg dissolved in 2
mL of 95% ethanol) was then added to each flask. The incubation with
the substrate was carried out for a further 72 hour period at which time
the flasks were filtered and worked-up as previously described in lb.
The crude residues were then subjected to chromatographic analysis as
Incubation' 23
,1
Incubation of 1 (1.0 g) provided extracts from medium (0.6 g) and
mycelium (0.42 g). The latter contained starting material as the only
readily detectable compound (tlc) and was not examined further. The
extract from incubation medium was chromatographed on silica gel by
stepwise elution from benzene to ether (increments of 10% ether) to give
1 (0.27, 27%), identical with starting substrate, 37 (6 mg, 0.6%),
and 38 (2 mg, 0.2%). These isolated products were identified by mp,
tlc, and spectral comparison with the compounds obtained from previous
incubation ('1).
Incubation # 24
Canadine , 25
Incubation of 25 (0.2 g) gave 0.17 g of extract; tlc and mass
spectral analysis indicated the absence of transformation products.
Recrystallization from methanol provided only 25 (0.15 g, 75%
recovery), identical with starting substrate.
Incubation' 25
'~
Incubation of 26 (0.2 g) gave 0.18 g of extract which gave a spot
on tIc with Rf identical to that of a genuine sample of 25 and a
couple of spots with higher Rf values. There was no indication of
more polar oxidation products. Further analysis mass spectrometry
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revealed the presence of only starting material. Purification afforded
only ~ (0.165 g, 82.5% recovery), identical with starting material
Incubation :# 26
, 27
Incubation of 27 (0.2 g) gave 0.175 g of crude extract. Thin
layer chromatography indicated the only component to be the starting
material. The crude extract was further analysed by mass spectrometry
which showed that 12 was the only compound present. The extract was
recrystallized from methanol to give 27 (0.155 g, 77.5% recovery),
identical with starting material.
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3. Incubations with Mortierella isabellina NRRL 1757 114
a Preparation and Growth Conditions of Fungal Cultures
The growth medium for the fungus consisted of glucose (40 g), soya
bean meal (5 g), yeast extract (5 g), sodium chloride (5 g), and
potassium phosphate (dibasic) (5 g) per Litre of distilled water. One
hundred and fifty mL of the above medium was placed in one Litre
Erlenmeyer flasks, fitted with sponge plugs, sterilized as described in
la, allowed to cool and then inoculated with Mortierella isabellina
from growing slopes, under sterile conditions. The flasks were then
placed on a rotary shaker, 150 rev./min. at 25°C.
b. General Design of Experiments
After three days (72 hours) of growth under the conditions
mentioned above, the flasks were removed from the shaker, filtered,
mycelia washed two times with distilled water and then resuspended in
distilled water (150 mL/flask). The substrate dissolved in 95% ethanol
(100 mg/2 mL) was added to each flask. Incubation was then continued
under the similar conditions as described above for 72 hours.
work-up was identical to that described for other cultures.
The extracts were filtered through 0< -cellulose, if necessary. The
crude residues obtained were then subjected to chromatography as
required.
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Incubation # 27
'!
Incubation of 1 (0.5 g) gave extracts from mycelium (0.62 g) and
medium (0.070 g). The former contained ! as the only readily
detectable compound. The latter extract was chromatographed on silica
gel by stepwise elution from benzene to ether (increments of 10% ether)
to give dibenzothiophene,! (20 mg, 4%) identical with authentic
material; dibenzothiophene-9,9-dioxide, 1L (25 mg, 5% yield), and
dibenzothiophene-9-oxide, 38 (5 mg, 1% yield), identified by comparison
of spectral and physical properties with products, 37 and 38
obtained from previous incubations.
Incubation # 28
, 20
Incubation of 20 (0.9 g) gave extracts from medium (0.5 g) and
mycelium (0.8 g). The latter contained starting material as the only
readily detectable component (tic) and was not examined further. The
extract from incubation medium was chromatographed on silica gel using a
benzene to ether solvent gradient (s of 10% ether). This provided
20 (0.06 g, 6.7%), identified by comparison with an authentic sample;
thioxanthone-l0,10-dioxide, 43 (6 mg, 0.6%), and thioxanthone-10-oxide,
44 (10 mg, 1%). these products were identified by comparison of tic,
mp, and spectral data of products obtained from incubation # 18.
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Section B
Microbial Oxidation of Alkylbenzenes by
Mortierella isabellina NRRL 1757
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The growth of the fungus, the incubation procedure and the work-up
procedure were followed as stated in the previous experimental section.
Incubation # 29
, 28a
Incubation of 28a (0.6 g) gave extracts from mycelium (0.6 g) and
medium (0.3 g). The former extract showed (tIc and nmr) no metabolic
product and was discarded. The latter extract was applied to the top of
a silica gel column. The column was eluted with benzene-ether
(increments of 5% ether) to afford in order of decreasing Rf ,
ethylbenzene, 28a (0.12 g, 12%) and l-phenylethanol, 51a (0.1 g, 10%
yield); 1H NMR b : 1.2 (3H,d,J=6Hz), 2.7 (1H,s), 4.75 (lH,q,J=6Hz)
and 7.2 (5H,s); MS mle (io): 122 (12,M+·), 120 (19), 105 (80), 104
(68), 91 (48), 79 (45), 78 (57), 77 (100)
Incubation of ethylbenzene 28a with M. isabellina was repeated
under the same conditions as described before but at different
concentration levels.
(i) Incubation of 28a (0.5 g, 125 mg/flask) provided extracts from
medium (0.2 g) and mycelium (0.25 g). TLC analysis of latter extract
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revealed the presence of material plus some endogenous fungal
products. The former was chromatographed, as described above, and
yielded l-phenylethanol, 51a (80 mg, 16%).
(ii) Incubation of 28a (0.5 g, 50 mg/flask) gave extracts from
mycelium (0.4g) and medium (0.18 g). The former indicated the presence
of starting substrate and some non polar oxidation product. The crude
extract from incubation medium revealed (nmr) the presence of metabolic
product. The column chromatography of this extract, as described above,
gave very small amount of product which was not sufficient for spectral
analysis and further investigations.
Incubation # 30
p-Ethyltoluene , 28b
Incubation of 28b (1.0 g) provided extracts from the medium (0.17
g) and mycelium (0.4 g). The latter contained endogenous fungal
material and 28b as the only readily detectable compound. The former
extract was chromatographed on silica gel using benzene-ether gradient
elution (steps of 5% ether) and afforded 28b (0.07 g);
1-(p-methylphenyl)ethanol, 51b (38 mg, 3.8'70); 1H NMR 6: 1.43
(3H,d,J=6Hz), 2.05 (lH,s), 2.3 (3H,s), 4.8 (lH,q,J=6Hz), and 7.15
(4H,m); MS m/e (%): 136 (48, ), 121 (54), 118 (22), 117 (44), 107
(21), 105 (100), 93 (36), 77 (36); and 2-(p-methylphenyl)ethanol, 52a
(10 mg, 0.1%); l H NMR S :2.35 (3H,s), 2.8 (2H,t,J=6Hz), 3.8
(2H,t,J=6Hz), and 7.05 (4H,s); MS m/e (%): 136 (22,M+·), 118 (27),
105 (100), 103 (11), 91 (28), 79 (14), 77 (18)
Incubation # 31
, 28c
Incubation of 28c (1.0 g) gave extracts from mycelium (0.35 g)
and medium (0.32 g). The former contained 28c and some natural fungal
products (tIc) and was not examined further. The latter was applied to
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a column of silica gel in benzene. The column was eluted with
benzene-ether (increments of 5% ether) to give in order of elution, 28c
(0.11 g, 11%), identical in all respects with starting material;
1l-(p-ethylphenyl)ethanol, 51c (27 mg, 2.710); H NMR S: 1.2 (3H,t),
1.35 (3H,d), 2.58 (2H,q), 3.45 (1H,s), 4.7 (lH,q), and 6.98 (4H,s); MS
mle (%): 150 (15,M+·), 135 (62), 132 (42), 117 (100), 107 (14), 105
(32), 79 (83), 77 (43); and l-(p-acetylphenyl)ethanol, ~ (6 mg, 0.6%);
l H NMR b: 1.5 (3H,d,J=7Hz), 4.93 (lH,q,J=7Hz), and 7.38, 7.88
(4H,AB quartet,J=8Hz); MS mls (%): 164 (5,M+·), 149 (60), 131 (26),
121 (66), 103 (25), 91 (11), 77 (26), 43 (100). A total of 0.03 g more
polar fractions were also eluted which could not be identified,
therefore not investigated further.
Incubation :fI: 32
Incubation of 28d (1.0 g) provided extracts from the medium (0.29
g) and mycelium (0.41 g). The latter contained starting material as the
readily detectable compound (tlc) and was not examined further.
The extract from incubation medium was chromatographed on siica gel
using a benzene to ether solvent gradient (steps of 5% e This
in order of elution, p-methoxyethylbenzene (0.05 g, 5%);
1l-(p-methoxyphenyl)ethanol, 51d (0.1 g, 10%); H NMR S: 1.18
,d,J=7Hz), 3.68 (3H,s), 4.6 (lH,q,J=7Hz), and 6.68, 7.1 (4H,AB
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MS mle (%): 152 (26, ), 137 (100), 134 (70), 121
(15), 119 (34), 109 (44), 91 (45), 77 (36). This incubation also gave
traces of another hydroxylation metabolite (nmr),
2-(p-methoxyphenyl)ethanol, 52b which could not be isolated in pure
form and enough quantity for further investigations.
Incubation # 33
, 28e
Incubation of 28e (1.0 g) gave extracts from the mycelium (0.5 g)
and medium (0.19 g). the former contained 28e as the only readily
detectable compound. there was no sign of any polar oxidation product
and therefore it was not examined further. The latter extract was
chromatographed on silica gel using benzene-ether gradient elution
(steps of 5% ether). This provided, in order of decreasing Rf ,
p-fluoroethylbenzene (70 mg, 7%), identified by tIc and spectral
comparison with a sample of authentic material; and a component (60 mg,
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6%) with a lower value than the starting substrate. The second
component appeared (nmr) to be a mixture of l-(p-fluorophenyl)ethanol,
51e (87%) and 2-(p-fluorophenyl)ethanol, 52c (13%). These isomers
could not be separated by column chromatography, therefore the mixture
was analysed qualitatively and used for further investigations. the
NMR included signals at S: 1.58 (3H,dJ=6Hz), 2.83 (2H,t,J=6Hz),
3.75 (2H,d, , 4.8 (lH,q,J=6Hz), and 7.13, 7.33 (4H,AB
,J=8Hz). The mass spectrum showed the following fragmentation
m/e (%): 140 (15,M+·), 122 (27), 117 (12), 109 (100), 105
(19), 96 (10), 91 (22), 77 (25)
Incubation # 34
p-Chloroethylbenzene ,
Incubation of 28f (1.0 g) gave extracts from medium (0.17 g) and
mycelium (0.6 g). The latter contained 28f as the only readily
detectable compound (tlc and nmr). The former extract gave a single
spot on tlc with Rf lower than the starting material. This appeared
to be a mixture of l-(p-chlorophenyl)ethanol, 51£ (81%) and
2-(p-chlorophenyl)ethanol, 52d (19%). These isomers could not be
isolated in pure form by column chromatography. Thus the mixture was
analysed qualitatively and used for further investigations. The 1H
NMR of the mixture included peaks at &: 1.4 (3H,d,J=6Hz), 2.38
(lH,br,s), 2.75 (2H,t,J=6Hz), 4.8 (lH,q,J=6Hz), and 7.18 (4H,s). The
mass spectrum of the mixture showed the following fragmentation pattern,
m/e (%): 158 (5), 156 (17), 143 (19), 141 (64), 125 (29), 91 (17), 77
(100)
Incubation :fI: 35
p-Cyanoethylbenzene , 28g
Incubation of 28g (1.0 g) provided extracts from the medium (0.6
g) and mycelium (0.59 g). The latter contained endogenous fungal
material, plus 28g as the only readily detectable compound (tlc) and
was not examined further. The extract from the incubation medium gave a
single spot on tlc with Rf lower than starting material and was
therefore used for further investigations without any purification.
This compound was characterized as l-(p-cyanophenyl)ethanol, 51g (0.6
1g, 6070); H NMR 6: 1.45 (3H,d,J=7Hz), 3.73 (lH,s), 4.88
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(lH,q,J=6Hz), and 7.48 (4H,s); MS m/e (%): 147 (9,M+·), 132 (100),
129 (68), 128 (21), 116 (45), 104 (87), 102 (47), 77 (40)
Incubation :IF 36
p-Ethylaniline , 28h
Incubation of 28h (1.0 g) provided extracts from mycelium (0.49
g) and medium (0.53 g). The former contained 28h as the only readily
detectable compound (tlc). The latter extract was chromatographed on
silica gel by stepwise elution from benzene to ether (steps of 5% ether)
to give p-ethylaniline (0.28 g, 28io), and p-ethylacetanilide, 28i
(0.212 g, 21%), identified by mp, tlc, and spectral comparison with an
authentic sample, prepared as described in a previous experimental
section.
Incubation :IF 37
p-Ethylacetanilide , 28i
Incubation of 28i (1.0 g) gave extracts from medium (0.15 g) and
mycelium (0.4 g). Thin layer chromatography of both extracts indicated
1the absence of any transformation products. The H NMR of these
extracts was identical with starting substrate.
Incubation :JI: 38
158
, 28j
Incubation of 28j (1.0 g) provided extracts from mycelium (0.3 g)
and medium (0.76 g). Both the mycelium and medium extract appeared
(tic) to be unmetabolized substrate. Further analysis by l H NMR
showed that only starting material was present.
Incubation # 39
n-Propylbenzene , ~
Incubation of 29 (1.0 g) gave extracts from medium (0.64 g) and
mycelium (0.4 g). TLC analysis of latter extract showed that it
contained only 29. The former extract was chromatographed on silica
gel using benzene-ether solvent gradient elution (increments of 5%
ether) and afforded 29 (0.09 g, 9%) and l-phenylpropanol, 54 (0.45 g,
45% yield); l H NMR 6: 0.73 (3H,t,J=8Hz), 1.63 (2H,m), 3.13 (lH,s),
4.38 (lH,t,J=7 Hz), and 7.15 (5H,s); MS m/e (%): 136 (7,M+·), 118
(46), 115 (21), 107 (100), 105 (81), 91 (60), 79 (58), 77 (64).
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~H3
H-C-OH
R
51
-
a· R - HJ
b· R= CH3I
c· R - C2H5J
d· R= OCH 3J
e· R - FI
f · R= ClJ
gj R= CN
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R52
OJ R = CH3
b; R = OCH3
Cj R::::: F
d· R = ClI
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All incubations were performed by standard as previously
described. The only difference was that the rubber stoppers were used
in place of sponge plugs during incubation of fungus with substrate.
Work-up method was identical to that described before for other
cultures.
Incubation :f/: 40
Acetophenone , 33a
Incubation of 35a (0.50 g) gave extracts from medium (0.48 g) and
mycelium (0.2 g). The latter extract contained some endogenous fungal
material, plus 33a as the only readily detectable compound (tlc) and
was not examined further. The medium extract gave one spot on tlc
164
with Rf identical to that of
without further purification.
51a , and was therefore characterized
The compound was identified as
1-phenylethanol, 51a (0.435 g, 87% yield) comparison of
data of a genuine sample obtained from incubation :f/: 29.
Incubation :If 41
, 33c
Incubation of 33c (1.0 g) provided extracts from mycelium (0.31
g) and medium (0.59 g). TLC analysis of former extract revealed that it
contained 35c as the only detectable compound. The latter was
applied to the top of a column of silica gel. The column was eluted
with benzene-ether (increments of 5% ether) to give in order of elution,
33c (0.2 g), identical in all respects with starting material, and
l-(p-ethylphenyl)ethanol, 51c (0.07 g, 7% yield), identified by tic and
spectral comparison with an authentic sample obtained from incubation #
31.
Incubation # 42
0< ,0< ,o(-Trifluoroacetophenone , 36
Incubation of 36 (0.50 g) gave extracts from medium (0.43 g) and
mycelium (0.2 g). The latter contained natural fungal products in
addition to 36 as the only detectable compound (tic). The former
extract appeared (tic) to be a pure compound. Thus it was identified as
1-phenyl,2,2,2-tri£luoroethanol, 34 (0.43 g, 86%). Its l H NMR
spectrum showed peaks at 6: 4.0 (lH,br,s), 4.68 (lH,q), and 7.3 (5H,s).
The 19F NMR of the product included a signal at b: -77.4
(3F,d,J=6.6Hz). The mass spectrum showed the following fragmentation
pattern, m/e (%): 176 (26,M+·), 140 (29), 127 (17), 109 (13), 107
(100), 105 (37), 79 (64), 77 (72).
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PART THREE
Determination of Enantiomeric Excess
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1The enantiomeric enrichments were determined by the H NMR
chiral shift reagent method. Shift reagent, Eu(hfc)3 (Fig. 33) and
the chiral compound in study were dissolved in 0.5 mL of reagent grade
carbon tetrachloride. The molar ratio of shift reagent to chiral
compound was 0.2 - 0.3. In some cases more shift reagent was required
in order to increase the enantiomeric shift difference (AAb) of methyl
and ortho protons. The addition of shift reagent caused the downfield
shift of benzylic, methyl and ortho protons. The peak of the benzylic
and methyl protons which appeared as a quartet and doublet without shift
reagent, split into a multiplet and triplet (composed of two overlaping
quartets and doublets, respectively, from two enantiomers). By
irradiating at multiplet, the triplet collapsed to a resolved (A~SCa.
0.05 - 0.2 ppm) doublet. The relative peak areas were integrated and
the ratio of the enantiomers was calculated from the average of fifteen
to twenty integrations. In addition, the ortho protons also appeared as
a triplet (overlapping doublets) in the presence of Eu(hfc)3 while
the meta protons were still a doublet. By decoupling at the doublet
signal (meta protons), the triplet (ortho protons) collasped to two
167
of different peak areas (see appendix II). The integration of
these two peaks was also carried out fifteen to times and these
values were averaged to obtain the ratio of two enantiomers. The values
obtained from methyl and ortho protons were averaged (in most cases) to
determine the enantiomeric excess.
The results are presented in Table 8.
Figure 33. The structure of chiral shift reagent
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tris[3-(heptafluoropropylhydroxymethylene)-~-camphorat0]­
europium(III)
Table 8. Optical ties of products
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Incubation # Product Ratio of Enantiomers % Enantiomeric Excess %
29. 51a 67 33a 34
29(i). 51a 69 31 38
30. 51b 62 38 24
31. 5ic 68 32 36
32. 51d 66 34 32
33. 51e 56 44 12
34. 51f 67 33 34
35. 5ig 69 31 38
39. 54 b
40. 51a 92 08 84
41. 51c 100 00 100
42. 34 c
a Measured peak height because peaks were too close and
was not useful.
b Decoupling of ~ protons was not successful.
c Not determined due to nonavailability of heterodecoupling
ie 19F {lH} or vice versa.
PART FOUR
Determination of Specific Rotations
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Optical rotations were measured in 95% ethanol using 1 mL sample
cell at 21°e. The specific rotations were calculated using the
following equation.
171
0<
C 1
Where,
0( is the observed rotation in degrees.
e is the concentration in g/100 mL of solution.
1 is the length of the sample cell in decimeters.
t is the temperature in °e and
~ is the wave legnth.
The results are listed in Table 9.
The values of measured specific rotations so obtained were used
where possible to check the enantiomeric enrichments. For these
calculations, the specific rotations of pure enantiomers were used.
Table 9. Specific rotations of products and their absolute configurations
Incubation No. Product [0<] in 95% EtOH [oC] for the pure Concentration Configuration88 ,98,176
enantiomer (lit.) [g/100 mL
of solution]
16. 42 -14.04
--
2.77
--
19. 49 -6.67
--
0.27
29. 51a +12.65 43.9173 0.83 R
29(i). 51a +11.44 43.9173 1.25 R
.-
30. 51b +3.00
--
0.40 R
-
31. 51c +2.00
--
0.25 R
-
31. 53 +3.42
--
0.38
32. 51d -9.41 45. 1.02 S
-
33. 51e +38.68
--
0.91 R
-
34. 51f -4.04
--
4.43 S
--
35. 51g +10.33
--
8.56 R
39. 54 +12.98 55.54175 7.07
40. 51a -5.41 43.9173 3.57 S
-
41. 51c +73.93
--
0.56 R ~
.......
42. 34 -2.65 7.32 ~
--
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Incubation No. Substrate
Table 10. Summary of results
Fungus Compound/s isolated (%)
1.
2.
Dibenzothiophene, 1
Dibenzopyrrole, 2
c. elegans
c. elegans
Dibenzothiophene-9,9-dioxide,
37 (2.8)
Dibenzothiophene-9-oxide,
38 (0.5)
2-Hydroxydibenzopyrrole,
39 (1)
3. Fluorene, 1 c. elegans
4. 9-Fluorenone, ~ c. elegans
...........
5. Acridine, 1 c. elegans
6. Phenanthridine, i C. elegans
--
7. 1:10-Phenanthroline, 7 c. elegans
8. Benz[a]anthracene, ! C. elegans
9. Benz[c]acridine, ! C. elegans
10. Triphenylphosphine, 12 c. elegans
Starting material, 3 (40)
9-Hydroxyfluorene, 40 (1.4)
Structure not determined
Starting material, i (88)
Starting material, I (85)
Starting material, ! (76)
Starting material, ! (79)
Triphenylphosphine oxide,
41 (18)
t-'"
'-J
VI
Table 10, continued (p. 2)
Incubation No. Substrate
16. Thiochroman-4-one, 18
11. Dibenzo-l,4-dioxin, 13
13. Dibenzosuberone, ~
Compound/s isolated (%)
Starting material, ~ (65)
Starting material, 14 (100)
Starting material, ~ (100)
Starting material, ~ (
Starting material, 12 (69)
Thiochromanone-l-oxide,
42 (16)
Starting material, 19 (57)
Fungus
c. elegans
c. elegans
c. elegans
c. elegans
C. elegans
c. elegans
c. elegans2-Phenylthiochroman-4-one, 1917.
14. Thianaphthene, ..!!
12. 5H-Dibenzo[a,d]cyclohepten-5-one, 14
15. terthienyl, ..!l
18. Thioxanthan-9-one, 20 c. elegans Thioxanthone-l0,10-dioxide,
43 (2)
Thioxanthone-l0-oxide,
44 (0.5)
19. 1-Methylthioxanthone, 21 c. elegans l-Methylthioxanthone-
10,10-dioxide, 45 (2.5)
l-Hydroxymethylthioxanthone-
10-oxide, 49 (7) ~
.........
0"
Table 10 continued (p. 3)
Incubation No. Substrate Fungus Compound/s isolated (%)
20.
21.
22.
23.
2-Methylthioxanthone, 22
3-Methylthioxanthone, 23
4-Methylthioxanthone, 24
Dibenzothiophene, 1
C. elegans
C. elegans
C. elegans
Rhizopus
arrhizus
2-Methylthioxanthone-
10,10-dioxide, ~ (5)
3-Methylthioxanthone-
10,10-dioxide, ~ (4.4)
3-Hydroxymethylthioxanthone,
50 (6)
4-Methylthioxanthone-
10,10-dioxide, 48 (10)
Dibenzothiophene-9,9-dioxide
37 (0.6)
24.
25.
26.
Canadine, ~
Tetrahydropalmatine, 26
Corydaline, 27
Dibenzothiophene-9-oxide
38 (0.2)
R. arrhizus Starting material, ~ (75)
R. arrhizus Starting material, ~ (82.5)
R. arrhizus Starting material, 27 (77.5)
~
'-J
'-J
Table 10, continued • 4)
Incubation No. Substrate
27. Dibenzothiophene, 1
Fungus
Mortierella
isabellina
Compound/s isolated (%)
Dibenzothiophene-9,9-dioxide,
37 (5)
Dibenzothiophene-9-oxide,
38 (1)
28. Thioxanthan-9-one, 20 Mortierella
isabellina
Thioxanthone-l0,10-dioxide,
43 (0.6)
Thioxanthone-10-oxide,
44 (1)
......
........
00
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Incubation No. Substrate
Table 11. Summary of results
Compounds isolated (%) Enantiomeric excess %
NMR Rotation
29. Ethylbenzene, 28a 1-phenylethanol, 51a (10) 34 28.82
29(i). Ethylbenzene, 28a 1-phenylethanol, 51a (16) 38 26.10
30. p-Ethyltoluene, 28b l-(p-methylphenyl)ethanol 24
51b (3.8)
2-(p-methylphenyl)ethanol
52a (0.1)
31. p-Diethylbenzene, 28c l-(p-ethylphenyl)ethanol 36
51c (2.7)
1-(p-acetylphenyl)ethanol
53 (0.6)
32. p-Methoxyethylbenzene, 28d 1-(p-methoxyphenyl)ethanol 32 20.82
51d (10)
2-(p-methoxyphenyl)ethanol
.....
52b (*) 000
Table 11, continued (p. 2)
Incubation No. Substrate Compound/s isolated Enantiomeric excess %
NMR Rotation
33.
34.
35.
36.
37.
38.
39.
p-Fluoroethylbenzene, 28e
p-Chloroethylbenzene, 28£
p-Cyanoethylbenzene, 28g
p-Ethylaniline, 28h
p-Ethylacetanilide, 28i
p-Ethylphenol, 28j
n-Propylbenzene, 29
l-(p-fluorophenyl)ethanol
51e
2-(p-fluorophenyl)ethanol
52c (**)
l-(p-chlorophenyl)ethanol
51£
2-(p-chlorophenyl)ethanol
52d (**)
1-(p-cyanophenyl)ethanol
51g (60)
p-ethylacetanilide, 28i
(21)
starting material, 28i
(55)
starting material, 28g
(100)
1-phenylpropanol, 54
(45)
12
34
38
23.27
.....,.
00
.....,.
* Product detected (tIc) and qualitatively analysed (nmr) but not isolated in pure form.
** Two isomers were not isolated separately.
f-6
00
N
PART THREE
Microbial Reduction of Ketones by
Mortierella isabellina NRRL 1757
183
Incubation No. Substrate
Table 12. Summary of results
Compound/s isolated (%) Enantiomeric excess %
NMR Rotation
40
41.
42.
Acetophenone, 33a
p-Ethylacetophenone, 33c
f?(, 0( ,0( -Trifluoroacetophenone, 36
1-phenylethanol, 51a (87)
1-(p-ethylphenyl)ethanol
51c (7)
1-phenyl-2,2,2-trifluoro-
ethanol, 34 (87)
84
100
12.43
~
00
~
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Many chemical carcinogens are now known to be activated and
transformed in vivo into highly active metabolites. 177 ,178
Although the relevant metabolism for PACs has not received a great deal
of recent attention, however polycyclic aromatic hydrocarbons have been
the subject of intensive scrutiny.l0,11,S6,66,179,180,181
Of the fungi studied, ~ elegans has been the subject of much
recent study and is known to catalyse various reactions by cytochrome
64 179P-450 dependent monooxygenases.' This organism demonstrated a
high degree of parallelism to liver microsomal monooxygenase
t 11,56,64,67sys ems.
Of the aza heteroaromatics studied, only dibenzopyrrole,! gave a
cleanly isolable product, 2-hydroxydibenzopyrrole, ~. Fungal
dibenzofuran to 2-hydroxylated derivative by C.
oxidation of dibenzopyrrole at C-2 parallels the reported metabolism of
57
elegans. The
reaction sequence shown in Figure 34 is proposed for the metabolism of
dibenzopyrrole. No evidence for the formation of arene oxide was
obtained; it is proposed by analogy with the proposed pathway for fungal
hydroxylation of dibenzofuran at C-2, and also by the fact that most
arene oxides undergo spontaneous isomerization to form phenols.
Incubation in the presence of protein synthesis inhibitor, cycloheximide
(100~g/mL) did not show any significant inhibition of enzymic activity.
progesterone by
It is known that cycloheximide inhibits the hydroxylation of
158 when added at the
Figure 34. Proposed reaction sequence for the metabolism of
Dibenzopyrrole by ~ elegans
188
N
H H
H
H
OH
concentration of 100~g/mL, proving the inducible nature of progesterone
hydroxylating enzymes. However the results obtained in this s do
189
not necessarily mean that enzyme present in C. which is
to
responsible for hydroxylation of dibenzopyrrole is noninducible. The
difference between the two cases in respect of inducibility could be
explained by the fact that two different fungi are involved.
Acridine, 1 gave traces of an oxidized product which was partially
characterized (see experimental) as a ring hydroxylated product but
could not be isolated in sufficient quantity for complete
characterization. The induction of enzyme activity was unsuccessful
attempted by the addition of substrate during the growth period of the
fungi. The corresponding polynuclear hydrocarbon, anthracene, has been
181
recently reported to be oxidized by C.
transdihydrodiols.
Incubation of phenanthridine, ~ with C. showed no sign
of any metabolic product. 44In contrast, Benson and coworkers
observed the metabolism of this compound by rat lung and liver
microsomes to several more polar metabolites. The pattern of
metabolites produced by lung and liver is qualitatively similar.
Phenanthrene, the analogous hydrocarbon has been to be
b 1 · d b b · 182 d f .181 d·· dmeta 0 1ze y acter1a an ung1 to correspon 1ng C1S an
~ dihydrodiols, respectively.
1:10 Phenthanroline, land benz[c]acridine, 9 were recovered
unchanged after incubation with C. However, Jacob
et 42al have recently reported the metabolic activation of
190
benz[c]acridine by rat liver and lung microsomes.
A wide variety of thia heteroaromatics were incubated with
different fungi. The results are presented in Table 10.
Dibenzothiophene, 1 gave two products on incubation with all the three
fungi studied. The products were identified as the corresponding
sulphone, 37 and sulphoxide, 38. No ring hydroxylated products were
detected. The differences in yield of two metabolites with different
fungi may be due to many factors. For instance, the optimum conditions
used for incubations may not represent the optimum conditions for
dibenzothiophene biotransformation. Also the yield of metabolites
depends upon factors such as supply of nutrients, incubation time,
temperature and pH.
114 183 184Although earlier workers ' , have reported that
sulphides are metabolized to the corresponding sulphoxides and sulphones
by a range of fungi, to our knowledge the present results constitute the
first example of fungal oxidation of sulphur in a heteroaromatic ring.
Since the metabolic route is unique and the products formed to a lesser
extent by fungi, certain control experiments are required to establish
the dependence of this pathway on enzymic systems. The incubation of
dibenzothiophene was performed with an autoclaved culture of C.
; in these conditions no product was detected, confirming that
the products were indeed derived from an enzymic process. The formation
of products by C. was not inhibited by cycloheximide which
191
suggests that enzyme is non-inducible. To obtain more convincing
results about the inducible nature of enzyme, it is necessary to carry
out these incubations in the presence of classical cytochrome P-450
inhibitors, metyrapone and SKF 525-A. The corresponding bicyclic
compound thianaphthene, ~ was not metabolized by C. elegans.
This
Previous reports of the bacterial metabolism of dibenzothiophene
o dO d h f 0 f 0 °d o ddt 185,1861n 1cate t e ormat10n 0 r1ng OX1 1ze prouc s.
contrast between the metabolic pathways of bacteria and fungi may be
metabolism. However, it would be of interest to see if mammalian
sulphoxide, 44 were obtained in both the cases, but the former
predominating in the case of C. elegans while the latter was the
Interestingly, the
Thioxanthan-9-one, 20 was found to be oxidized at sulphur by both
microsomal systems show similar metabolic routes to that observed with
significant in view of the use of fungi as models for mammalian
C. elegans and M. isabellina. Corresponding sulphone, ~ and
major product in the case of M. isabellina.
fungal systems.
corresponding bicyclic compound, thiochroman-4-one, ~ was
stereoselectively metabolized to thiochromanone-1-oxide, ~ by C.
the metabolism of organic sulphides by M.et
This observation is consistent with the findings of Holland
al 102 who
isabellina to optically active sulphoxides. Auret and coworkers187
reported similar results with Aspergillus niger.
2-Phenylthiochromanone, ~ was not metabolized at all. This may
be explained on the basis of fact that carbon adjacent to sulphur
possesses a bulky substituent which might have sterically hindered the
attack of oxidizing species on the sulphur atom.
P - kl14 ,149,150 - h 1 h-d h - d- d hreV10US wor W1t su p 1 es as 1n 1cate t at
oxidation at sulphur is a stepwise process; the intermediate has been
formulated as the radical cation (Figs. 30 and 35). The intermediate
will not possess the regular tetrahedral geometry characteristic of
sulphides and can invert at room temperature. Therefore, it can be
proposed that the optical purity and absolute stereochemistry of the
product are dependent on the extent of stereospecificity of binding in
active site and the stability of radical cation intermediate.
All the four methyl substituted thioxanthones, ~ , ~ , 23 and
24 were actively converted to corresp.onding sulphones ~, 46 , 47
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and 48 by C. elegans. In addition this fungus also metabolized
l-methylthioxanthone, ~ to optically active
1-hydroxymethylthioxanthone-10-oxide, 49. In contrast the
3-methylthioxanthone, ~ was converted to 3-hydroxymethylthioxanthone,
50. It is possible that the enzyme that catalyses sulphoxygenation
also carries out methyl group hydroxylation. The presence and position
of the methyl substituent in the aromatic ring affected the
regioselectivi of the enzyme and thus changed the metabolite
Thus, the results indicate that the fungal enzymes show considerable
variation in the regio-selective metabolism of methylthioxanthones. It
would be necessary to perform the incubation of 3-methylthioxanthone, ~
Figure 35. Mechanism of enzymic sulphide oxidation
Or
193
18
under an 02 atmosphere to determine whether hydroxylation and
su1phoxygenation are both catalysed by a monooxygenase.
R 1 C · 1· d k 179 h d h h. ecent y ern1g 1a an cowor ers ave reporte t at t e
fungus C. elegans oxidises 4-methylbenz[a]anthracene primari
methyl group with further oxidation and enzymic hydration to form
various dihydrodiols (Fig. 36). Incubation under 1802
atmosphere and subsequent mass spectral analysis of metabolites
at the
194
indicated that both methyl group and aromatic ring are hydroxylated by
the biotransformation catalysed by cytochrome P-450 dependent
180
monooxygenase. The same authors have reported that 1- and
2-methylnaphtha1enes are also hydroxylated by C. elegans, primarily
at the methyl group (Fig. 37), and the metabolism is catalysed by a
monooxygenase.
Incubation of fluorene, 1 and benz[a]anthracene,! showed no sign
of biotransformation. In contrast, bacterial and mammalian metabolism
of benz[a]anthracene has been reported by various groups.50,188,189
Of the polycyclic aromatic ketones studied, only 9-f1uorenone, 4
was metabolized by C. e1egans to 9-hydroxyf1uorene, 40. Reduction
of keto group of fluorenone is interesting since it represents a common
1 · b· f · 74mamma 1an 10trans ormat10n. Fungal reduction of carbonyl group
of 4 to alcohol is te similar to the reported conversion of
f1 f1 1 b 1 · · 1 · 190 duorenone touoreno y 1ver m1crosoma preparat10ns, an
likewise is similarly assumed to be catalysed NADPH-cytochrome P-450
reductase and NADPH. This metabolism suggests close similarity between
Figure 36. Microbial metabolism of 4-methylbenz[a]anthracene by the
fungus ~ elegans
195
Cytochrome P-450
(i)
(ii)
18Cytochrome P-450, 02
Epoxidehydrolase, H20
Figure 37. Transformation of 1- and 2-Methylnaphthalenes by ~ elegans
196
00
the fungal and mammalian metabolism.
The only phosphorus containing compound, triphenylphosphine, 12
used in this study appeared to be principally converted to
triphenylphosphine oxide, 41 by the fungi used. However, the control
experiment carried out using an autoclaved culture of C. elegans
revealed the formation of same product and up to the similar extent,
thereby indicating the nonenzymatic formation of triphenylphosphine
oxide, 41 •
The results obtained in this study demonstrate that C. elegans a
typical soil fungus has the ability to oxidize many important
environmental pollutants. Possible comparisons of fungal vs. mammalian
transformations indicated that metabolites are identical. Thus, the
possibility exists that further studies will lead to the identification
of new products that have yet to be detected as mammalian metabolites.
In addition, the relative importance of these reactions in the
degradation of polycyclic aromatic compounds in natural ecosystems may
be established.
Despite the variety of reactions and the diversity of the
substrates which are metabolized, the fungus show in many cases
197
regiospecificity and stereoselectivi
by mul forms of cytochrome P-450
This may partly be contributed
in the fungi. It would be
interesting to examine the effects of classical cytochrome P-450
inducers (e.g., phenobarbital, 3-methylcholanthrene and polychlorinated
biphenyls) on variable enzyme activity in this organism.
Although many metabolites were estimated to occur in low yields, it
should be emphasized that it is usually possible to improve yields by
varying a number of incubation parameters. Among the experimental
conditions which may be changed for this purpose are: medium
composition, time of substrate addition, time of incubation with
substrate, the degree of aeration, and the use of inducers.
The incubations of many compounds with C. elegans and R.
arrhizus failed to produce corresponding oxidation products. In all
these cases, only starting material was recovered. There are three
possibilities that may explain why problems were encountered with the
possible metabolism. The first possibility is that the substrate was
unable to cross the cell membrane. The second is that the substrate
could not enter the active site of the enzyme and the third, that the
substrate was toxic to the fungi or acted as an inhibitor to enzyme.
Since most of the starting materials were recovered through extraction
from fungal mycelia, however, the inactivity of the enzyme is not due to
the inability of the substrate to enter the cell, but with enzyme
itself. It may be assumed that apoenzyme was incapable to orient the
substrate correctly for reaction. In dealing with the membrane bound
enzymes these problems are not unexpected. The possibility that these
substrates were lethal to the fungus, al not proven, is unlikely.
It seems probable that cytochrome P-450 is responsible for the
198
oxidation of various substrates by C. This conclusion is
based on the observation that in certain cases, there existed a stronger
199
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In addition to environmental concerns, many fungi are also
important for synthetic purposes in view of their broad substrate
specificity and high regio and stereoselectivity. Therefore, fungus is
a unique catalyst which can also be exploited by synthetic organic
chemist to achieve his/her goals which may otherwise challenge his or
her synthetic ingenuity and skill.
102 114 .Holland and coworkers·' observed that a ser1es of alkyl
aryl sulphides on incubation with Mortierella isabe1lina resulted in
stereoselective transformation to the corresponding sulphoxides and the
stereose1ectivity of S oxidation is susceptible to electronic
character of para substituent. They proposed that cytochrome P-450
dependent monooxygenase enzymes of the fungus were responsible for
oxidation at sulphur. They also observed that the hydroxylation of
ethylbenzene to 1-phenylethanol is also carried out by the same enzyme
191
system. On the basis of these observations, similar results were
proposed for the O<-hydroxylation of para-substituted ethylbenzenes by
M. isabellina under similar experimental conditions. It is therefore
the purpose of this study to investigate this hydroxylation with
ethylbenzene and its para-substituted derivatives.
The fungus Mortierella isabellina NRRL 1747 hydroxylated
para-substituted ethy1benzenes, 28a-g and propylbenzene, 1! to give
the corresponding 1-phenylethanols, 51a-g and 1-phenylpropanol, 54 ,
201
, with varying yields and optical ties; this is
summarized in Table 11. In the case of p-methyl, 28a ; p-methoxy, 28d
p-fluoro, 28e ; and p-chloroethylbenzene, 28f, the corresponding
2-phenylethanols 52a-d were also formed. Interestingly,
p-diethylbenzene was also metabolized to l-(p-acetylphenyl)ethanol, 53 •
p-Ethylaniline, 28h was actively converted to p-ethylacetanilide,
28i • No hydroxylation product was obtained. N-acetylation of aniline
is interesting since this represents a common mammalian
biotransformation observed particularly with aromatic amines,192,193
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This product is somewhat unexpected but by no means unique It was
demonstrated over a decade ago that a variety of fungi are capable of
transforming aniline to acetanilide. 72 On the other hand, Ferris
et al 66 reported that C. bainieri converts aniline to its
4-hydroxy derivative, a result which was confirmed by other
researchers. 72
p-Ethylacetanilide, 28i and p-ethylphenol, 28j were not
metabolized by M. isabellina at all. In contrast, Smith and
Rosazza72 have shown that acetanilide is principally converted to
2-hydroxyacetanilide and aniline by ~ ochraceous. Interestingly,
f h f 8 d 1 d h b f 8 81 8 72our ot er ung1 . eacety ate t e su strate orm1ng an1 1ne. The
of enzyme shown in the present study may be explained by
steric problems, caused the presence of ethyl moiety at para
position, in the active site of enzyme system. In a recent study,
McIntire and coworkers98 have indicated the formation of
l-(p-hydroxyphenyl)ethanol from p-ethylphenol by ~ and highly
purified p-cresol methylhydroxylase, an unusual flavocytochrome. In
both the cases, an excess of (S)-(-) enantiomer was observed.
The results obtained in this study (Table 11) clearly indicate that
major metabolic pathway involves oC-hydroxylation of substrates, 28a-g
providing optically active alcohols, in all the cases.
To account for the formation of optically active alcohols, the
enzyme system/s must be able to distinguish between the enantiotopic
hydrogens at the prochiral carbon centre. In an enzymic system this can
be eas achieved by providing binding sites which are different in
size and shape and hence constituting an asymmetric environment in the
active site of the enzyme allowing the substrate to bind, preferably in
one way. The protein body, 'apoenzyme' is responsible for this
stereospecific binding (Fig. 38). In the case shown in Figure 38 where
stereospecific binding pockets for the substrate as well as fixed
stereospecific position of oxidizing species relative to the substrate
are assumed, only one enantiomer would be expected. Variation of Rand
R' should have no effect on optical purity whether the transformation
proceeds in two steps or is concerted.
Since the hydroxylation of substrates provided a mixture of two
enantiomers with one enantiomer in excess, the model of Figure 38 has to
be modified.
An alternate model may involve a loose binding of ethyl group in
the active site of enzyme. So if the reaction is a stepwise process and
203
Figure 38. Model for the binding of a para-substituted Alkylbenzene
R
Apoenzyme
~
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a cation radical intermediate is formed, there is possibility that
inversion of intermediate can occur whose extent would depend in on
its own stability. Since radicals are electron deficient, the nature of
the para substituent R could have an electronic effect which stabilizes
or destabilizes the radical intermediate, depending on whether the
substituent is electron donating or withdrawing. This would allow
inversion to occur more readily in the former and less readily in the
latter case, raising the possibility that the optical purity of product
should depend at least in part on the electronic character of para
substituent.
On the other hand, if the metabolic pathway involves the concerted
mechanism there should be no effect of para substituent as there is no
possibility of inversion and reaction is entirely from one side.
A comparison of the enantiomeric excesses of alcohols obtained from
isosteric substrates (Table 11) suggests that the ee is dependent on the
electron density at prochiral carbon center, in some cases. Thus with
substrates having substituents of similar steric size and different
electronic nature such as 28d/28c (para OCH3 vs. para C2HS)'
ee apparently increases from 32 to 36%. A similar effect is observed
for 28b/28g (para CH3 vs. para eN) where ee increases from 24 to
38%, sugges that, for these substrates, an increase in electron
withdrawal by the aromatic ring and the resultant destabilization of the
cation radical intermediate causes an increase of enantiomeric excess.
20S
In contras comparison of 28a and 28e (para H vs. para F) showed a
substantial decrease in ee from 34 to 12%, while in there
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should be a significant increase in ee as fluorine is a good
destabilizer of intermediate. The basis for this discrepancy is not
clear, however, this inconsistent observation and small magnitude of
increase in ee observed in previous two cases argue against the proposed
hypothesis that stereoselectivity is susceptible to electronic effect of
the substituent at the para position of the aromatic ring. The change
of absolute stereochemistry observed in the case of electron donating
and electron withdrawing substituents, OCH3 and Cl, respectively, is
not in agreement either with described model or with the proposed
hypothesis discussed above. It should be pointed out, however, that
comparison of optical purities of chiral alcohols with steric size of
para substituents also showed no correlation.
An alternate explanation for the inconsistent results obtained in
this study may be as follows. That there may be two forms of cytochrome
P-450, each catalysing the hydroxylation with opposite stereospecificity
and the difference in rate of metabolism by the two forms gives rise to
excess of one enantiomer. This metabolic pathway is independent of
electronic and/or steric property of para substituent. To investigate
this possibility the incubations with ethylbenzene were performed at
different concentrations with the hope that it might change the rate of
metabolism by two forms as each enzyme has its own specific K. The
m
products so obtained have essentially the same optical ty. These
results indicate that change of concentration of substrate in incubation
medium does not alter the K for the microbial metabolism.
m
Unpublished results194 from our laboratory show that the incubations
of ethylbenzene at different temperatures indicate no change in
enantiomeric excess of product, 1-phenylethanol. These two important
observations do not support the idea of more than one form of cytochrome
P-450 responsible for these hydroxylations to produce optically active
alcohols. However, more experiments are required to support this
observation. The possibility of different enzymes for different
substrates, although remote, definitely needs certain investigations.
Alternatively, a quantitatively altered metabolic pathway could
account for the discrepancies seen in the stereose1ective hydroxy1ations
of ethy1benzenes. It can be proposed that hydroxylation of these
substrates occurs by three distinct steps (Fig. 39) and at least one or
all three are stereose1ective. The first step is the formation of
1-pheny1ethano1, the second step is the oxidation to produce
acetophenone, and the third is the reduction to give optically active
a1coho 1.
S l · 195 d d· 1 b fome contro exper1ments con ucte 1n our a oratory a ter
the completion of this study revealed that incubation of
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1-('Il"'II.-""" ........ 'll" ............... _ ....... 7f
28c with M. isabe1lina for 24-48 hours gives
, 51c , without any detectable amount of
p-ethylacetophenone, 35c. When incubation was run for 72 hours,
significant amount of p-ethy1acetophenone, was obtained in addition to
1-(p-ethy1phenyl)ethano1. In this connection it sh6uld be noted that it
has been recently reported that transformation of fluoren-9-o1 to
208
Figure 39. Proposed metabolic pathway for the hydroxylation of Alkylbenzenes
~H3
H-C-H.
R R
R
R
fluoren-9-one by liver microsomal preparations involves cytochrome P-450
190
oxygenase. These observations support the view that
acetophenone is formed from 1-phenylethanol and this reaction is most
209
probably cytochrome P-450 dependent although not direc proved in the
present case. The reduction of acetophenone to 1-phenylethanol proceeds
with a very high degree of stereoselectivity has been shown in this
study. It must, therefore, be assumed that this step, at least in part,
contributes to the overall optical purity observed. In the absence of
any information regarding the stereoselectivity of preceding steps, no
definite conclusion can be drawn from this study.
Determination of optical purity of 1-phenylethanol obtained from 24
to 48 hours incubation of ethylbenzene and regular incubations of
(R)-(+), (S)-(-) and (RS)-(±)-1-phenylethanol with M. isabellina
would provide necessary information about the stereochemical approach of
first two steps of the proposed metabolic pathway.
It may be relevant in this context that the hydroxylation of 0(,0(
-d2-ethylbenzene aby ~ isabellina provided 1-phenylethanol and
the reaction was slower due to a deuterium isotope effect (kH/kn
= 1.4). l-Phenylethanol thus formed retained one deuterium atom (Fig. 40
A) 195 I ··1· ..• n a S1m1 ar 1nvest1gat10n,
1-(4-phenylethyl)-ethane-l,1-d2 was used as a substrate and
hydroxylation was observed to proceed with a significant deuterium
isotope effect which was found to be: kH/ku = 4.0 (Fig. 40
B).195
From the above investigations, it is clear that fungal
210
Figure 40. Hydroxylation of a,a-dz-ethylbenzene and
~(4-phenylethyl)-ethane-l,1,dZby Mortierella isabellina
A·
~H3
O-C-OH
CH3
H-C-OH
+
H-C-OH
I
CH3
CH
I 2
CH3
B.
hydroxylation of ethylbenzene apparently proceeded by the loss of
one of the O<-hydrogens of ethylbenzene. The KIE studies clearly
211
s __ .., ....... __ mechanism (Fig. 24 B). However, there still remained
the question whether hydroxylation occurred by retention of absolute
stereochemistry (front side displacement) or inversion of
(back side displacement). To answer this question, optically active
(S)(+)O<-d-ethylbenzene has been prepared and metabolic investigations
196
are currently in progress in our laboratory.
Formation of 2-arylethanol (in some cases) can be attributed to the
same enzyme which is responsible for the production of 1-arylethanol.
This assumption is based on the observation that the oxidation of
para-substituted phenyl and benzyl methyl sulphides is catalysed
cytochrome P-450 present in M. isabellina 114 (Fig. 41, A and B).
The assignment of absolute configuration of the predominant
enantiomers in Table 9 is based on the reported stereochemis of
chiral alcohols of known optical rotation in the case of 51a 88,89
and 51d .98 Other absolute configurations are based on the
observation that dextrorotatory
f e e 176con 19urat1on.
The observed optical rotations for
carbinols have R
ls were compared
with the values in the literature. The values so obtained for
enantiomeric enrichments sometimes differed from values obtained by
using n.m.r. shift method. The problem with these
rotation measurements is that in some cases a trace amount of lipid
Figure 41. Sulphide oxidation by Mortierella isabellina
212
A.
B.
R
R
R
R
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(from mycelia) was present in the sample even after repeated column
chromatography and this may have some optical rotation, thus
affecting the accurate measurements. Thus, value obtained from the
optical rotation measurements serve only as a rough check. However, the
chiral shift reagent employed in the present study performed admirably
in determining the enantiomeric excess of microbial products.
It is hoped that this study has demonstrated what an important and
fascinating field is open in the research of fungal hydroxylations.
Future
possible that this fungus can provide better results.
Future prospect in this field is the research on these
Therefore, it is
This fungus is capable of
the same sulphoxidation reactions as M. isabellina, but with opposite
hydroxylations using Helminthosporium
f e e d 11 t 1·· 197con 19urat10n an exce en stereose ect1v1ty.
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